Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.

Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Translational andrology and urology   12 ( 2 )   161 - 167   2023.2

Combination of Muscle Quantity and Quality Is Useful to Assess the Necessity of Surveillance after a 5-Year Cancer-Free Period in Patients Who Undergo Radical Cystectomy: A Multi-Institutional Retrospective Study.

Fujita N, Momota M, Horiguchi H, Hamano I, Mikami J, Hatakeyama S, Ito H, Yoneyama T, Hashimoto Y, Nishimura S, Yoshikawa K, Ohyama C

Cancers   15 ( 5 )   2023.2

Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study.

Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C

The Prostate   83 ( 2 )   198 - 203   2023.2

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study.

Fujita N, Momota M, Ozaki Y, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

The world journal of men's health   2023.1

Association between Advanced Glycation End-Products, Carotenoids, and Severe Erectile Dysfunction.

Fujita N, Ishida M, Iwane T, Suganuma H, Matsumoto M, Hatakeyama S, Yoneyama T, Hashimoto Y, Mikami T, Itoh K, Ohyama C

The world journal of men's health   41 ( 3 )   701 - 711   2023.1

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

PloS one   18 ( 2 )   e0275921   2023

Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers.

Togashi K, Hatakeyama S, Soma O, Okita K, Fujita N, Tanaka T, Noro D, Horiguchi H, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Cancers   14 ( 24 )   2022.12

Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study.

Kai Ozaki, Shingo Hatakeyama, Shintaro Narita, Kenichi Hata, Takafumi Yanagisawa, Toshikazu Tanaka, Kyo Togashi, Tomoko Hamaya, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takahiro Kimura, Tomonori Habuchi, Chikara Ohyama

World journal of urology   41 ( 1 )   67 - 75   2022.12

Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction.

Miura H, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Tanaka R, Noro D, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   41 ( 5 )   254.e17 - 254.e24   2022.12

Association of oxidative stress with erectile dysfunction in community-dwelling men and men on dialysis.

Fujita N, Momota M, Ishida M, Iwane T, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Yamaya K, Ohyama C

The aging male : the official journal of the International Society for the Study of the Aging Male   25 ( 1 )   193 - 201   2022.12

Relationships of low-grade systemic inflammation and nutritional status with erectile dysfunction severity in men on dialysis.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Tomoko Hamaya, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Andrology   10 ( 8 )   1548 - 1555   2022.11

Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids.

Noritaka Ishii, Shingo Hatakeyama, Tohru Yoneyama, Ryuma Tanaka, Takuma Narita, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   40 ( 10 )   451.e1 - 451.e8   2022.10

Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Scientific reports   12 ( 1 )   13786 - 13786   2022.8

Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   29 ( 8 )   867 - 875   2022.8

転移性腎細胞癌に対するニボルマブ・イピリムマブ併用療法の使用成績

尾崎 魁, 鈴木 裕一朗, 畠山 真吾, 沼倉 一幸, 田中 壽和, 得居 範子, 伊藤 弘之, 野呂 大輔, 吉川 和暁, 米山 高弘, 橋本 安弘, 羽渕 友則, 大山 力

泌尿器外科   35 ( 臨増 )   826 - 826   2022.7

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy.

Hiromichi Iwamura, Shingo Hatakeyama, Takuma Narita, Yusuke Ozaki, Sakae Konishi, Hirotaka Horiguchi, Hirotake Kodama, Yuta Kojima, Naoki Fujita, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Scientific reports   12 ( 1 )   9675 - 9675   2022.6

ASSOCIATION OF PREDIABETES WITH RETINAL MICROVASCULATURE ON SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN THE ELDERLY: OTASSHA Study.

Wang Y, Toyama T, Hashimoto Y, Kawai H, Azuma K, Shiraya T, Kato S, Watanabe Y, Hirano H, Fujiwara Y, Ihara K, Kim H, Numaga J, Obuchi S, Ueta T

Retina (Philadelphia, Pa.)   42 ( 6 )   1130 - 1136   2022.6

【デジタル革命が導く遠隔医療とAI】Deep learningによる転移性前立腺がんのCRPC進展予測とその問題点

畠山 真吾, 米山 徹, 岡本 哲平, 成田 拓磨, 岩村 大径, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力

泌尿器科   15 ( 6 )   646 - 652   2022.6

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

The world journal of men's health   41 ( 2 )   373 - 381   2022.5

Renal metastasis of ovarian granulosa cell tumor.

Kyo Togashi, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Masayuki Futagami, Chikara Ohyama

IJU case reports   5 ( 3 )   186 - 190   2022.5

ロボット支援前立腺全摘術後患者におけるフレイルとQOLおよび下部尿路症状の関連性についての検討(FRARP-QL Study)

富樫 赳, 畠山 真吾, 岩村 大径, 小島 由太, 岡本 哲平, 米山 徹, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力

日本老年泌尿器科学会誌   35 ( 1 )   160 - 160   2022.5

Partial mycoheterotrophy in green plants forming Paris-type arbuscular mycorrhiza requires a thorough investigation.

Murata-Kato S, Sato R, Abe S, Hashimoto Y, Yamagishi H, Yokoyama J, Tomimatsu H

The New phytologist   234 ( 4 )   1112 - 1118   2022.5

TMEM2 expression is downregulated as bladder cancer invades the muscle layer.

Mihoko Sutoh Yoneyama, Tohru Yoneyama, Yuki Tobisawa, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tadashi Suzuki, Chikara Ohyama

Biochemical and biophysical research communications   613   1 - 6   2022.4

Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients.

Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama

Scientific reports   12 ( 1 )   5876 - 5876   2022.4

RS3PE症候群を契機に診断された重複癌(腎癌・前立腺癌)の一例

成田 拓磨, 小玉 寛健, 堀口 裕貴, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人, 畠山 真吾, 米山 高弘, 橋本 安弘, 大山 力

泌尿器外科   35 ( 4 )   358 - 358   2022.4

Everolimusが著効した類上皮性腎血管筋脂肪腫術後肺転移の1例

小西 栄, 橋本 安弘, 尾崎 佑輔, 堀口 裕貴, 小玉 寛健, 成田 拓磨, 岩村 大径, 小島 由太, 藤田 尚紀, 岡本 哲平, 山本 勇人, 畠山 真吾, 米山 高弘, 大山 力

泌尿器外科   35 ( 4 )   360 - 360   2022.4

COVID-19流行下における脳死下臓器提供と献腎移植5例の経験

濱谷 智子, 畠山 真吾, 小玉 寛健, 百田 匡毅, 濱野 逸人, 成田 拓磨, 岩村 大径, 小島 由太, 村澤 洋美, 杉山 尚樹, 山本 勇人, 米山 高弘, 橋本 安弘, 齋藤 久夫, 大山 力

泌尿器外科   35 ( 4 )   355 - 355   2022.4

Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.

Kyo Togashi, Shingo Hatakeyama, Tohru Yoneyama, Tomoko Hamaya, Takuma Narita, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   29 ( 7 )   733 - 739   2022.3

Effect of advanced glycation end products on nocturia or sleep disorders: A longitudinal study.

Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Kazutaka Okita, Koichi Kido, Yusuke Ozaki, Nozomi Uemura, Takuro Iwane, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJUI compass   3 ( 2 )   162 - 168   2022.3

Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.

Yoshiharu Okuyama, Shingo Hatakeyama, Kazuyuki Numakura, Takuma Narita, Toshikazu Tanaka, Yuki Miura, Daichi Sasaki, Daisuke Noro, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Shintaro Narita, Takahiro Yoneyama, Yasuhiro Hashimoto, Tomonori Habuchi, Chikara Ohyama

BJUI compass   3 ( 2 )   154 - 161   2022.3

Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer.

Yuki Miura, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hirotaka Horiguchi, Yoshiharu Okuyama, Yuta Kojima, Daisuke Noro, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJUI compass   3 ( 2 )   146 - 153   2022.3

The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma.

Kai Ozaki, Shingo Hatakeyama, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Hirotaka Horiguchi, Yoshiharu Okuyama, Naoki Fujita, Teppei Okamoto, Akiko Okamoto, Yuichiro Suzuki, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJUI compass   3 ( 2 )   139 - 145   2022.3

Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study.

Daichi Sasaki, Shingo Hatakeyama, Hideo Kawaguchi, Yoshiomi Hatayama, Yusuke Ishibashi, Ayumu Kusaka, Daisuke Noro, Toshikazu Tanaka, Hiroyuki Ito, Yoshiharu Okuyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Masahiko Aoki, Chikara Ohyama

Urologic oncology   40 ( 2 )   64.e1-64.e8 - 64.e8   2022.2

CRPCにおけるリキッドバイオプシー 糖鎖とcfDNAを用いた検討

畠山 真吾, 米山 徹, 濱野 逸人, 久保田 優花, 松本 哲平, 成田 拓磨, 藤田 尚紀, 岡本 哲平, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力

泌尿器科   15 ( 1 )   83 - 91   2022.1

腎移植後症例に対するダプロデュスタット12か月投与における有効性と安全性

村上 礼一, 日村 美玲, 奈川 大輝, 金城 育代, 藤田 雄, 島田 美智子, 富田 泰史, 畠山 真吾, 米山 高弘, 橋本 安弘, 大山 力

移植   57 ( Supplement )   s289_1 - s289_1   2022

Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma.

Kai Ozaki, Shingo Hatakeyama, Tomoko Hamaya, Kazutaka Okita, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   29 ( 4 )   362 - 364   2021.12

The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma.

Kazutaka Okita, Shingo Hatakeyama, Kazuhisa Hagiwara, Yuichiro Suzuki, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Naoki Fujita, Sakae Konishi, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   39 ( 12 )   832.e17-832.e23 - 832.e23   2021.12

Associations of impaired grip strength and gait function with the severity of erectile dysfunction in men undergoing dialysis: a cross-sectional study.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

The aging male : the official journal of the International Society for the Study of the Aging Male   25 ( 1 )   1 - 7   2021.12

Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.

Tohru Yoneyama, Hayato Yamamoto, Mihoko Sutoh Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Takuma Narita, Hirotake Kodama, Masaki Momota, Hiroyuki Ito, Shintaro Narita, Fumiyasu Tsushima, Koji Mitsuzuka, Takahiro Yoneyama, Yasuhiro Hashimoto, Wilhelmina Duivenvoorden, Jehonathan H Pinthus, Shingo Kakeda, Akihiro Ito, Norihiko Tsuchiya, Tomonori Habuchi, Chikara Ohyama

The Prostate   81 ( 16 )   1411 - 1427   2021.12

転移性腎癌治療に対してニボルマブ-イピリムマブ併用療法(N-I療法)の有効性と安全性の検討

得居 範子, 田中 壽和, 畠山 真吾, 野呂 大輔, 細越 正吾, 及川 真亮, 山本 勇人, 伊藤 弘之, 米山 高弘, 橋本 安弘, 川口 俊明, 羽渕 友則, 大山 力

日本泌尿器科学会総会   109回   PP01 - 05   2021.12

転移性腎細胞癌に対する一次治療としてニボルマブ+イピリムマブとチロシンキナーゼ阻害剤の比較検討 後方視的多施設共同研究

野呂 大輔, 畠山 真吾, 沼倉 一幸, 城戸 宏一, 田中 壽和, 及川 真亮, 細越 正吾, 米山 高弘, 橋本 安弘, 羽渕 友則, 大山 力

日本泌尿器科学会総会   109回   PP04 - 03   2021.12

転移性腎細胞癌に対する一次治療としてニボルマブ+イピリムマブとチロシンキナーゼ阻害剤の比較検討 後方視的多施設共同研究

野呂 大輔, 畠山 真吾, 沼倉 一幸, 城戸 宏一, 田中 壽和, 及川 真亮, 細越 正吾, 米山 高弘, 橋本 安弘, 羽渕 友則, 大山 力

日本泌尿器科学会総会   109回   PP04 - 03   2021.12

フレイルと合併症は限局性前立腺癌の治療選択に関与する因子である

小玉 寛健, 畠山 真吾, 岡本 哲平, 米山 徹, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力

日本泌尿器科学会総会   109回   PP33 - 04   2021.12

イムノグロブリンN-glycan signatureによる尿路上皮癌の診断法

小玉 寛健, 米山 徹, 田中 壽和, 野呂 大輔, 飛澤 悠葵, 山本 勇人, 須藤 晋一郎, 畠山 真吾, 米山 高弘, 橋本 安弘, 柿崎 育子, 中路 重之, 大山 力

日本泌尿器科学会総会   109回   AOP07 - 01   2021.12

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries.

Sakae Konishi, Takuma Narita, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Yuki Tobisawa, Daisuke Noro, Tendo Sato, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Scientific reports   11 ( 1 )   22103 - 22103   2021.11

Whole Body MRIにて病勢評価が可能であった去勢抵抗性前立腺癌(CRPC)の1例

細越 正吾, 畠山 真吾, 米山 徹, 米山 高弘, 橋本 安弘, 大山 力

泌尿器外科   34 ( 11 )   1288 - 1288   2021.11

Cell-free DNA(cfDNA)を測定した去勢抵抗性前立腺癌(CRPC)の1例

濱野 逸人, 畠山 真吾, 米山 徹, 鈴木 裕一朗, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 大山 力

泌尿器外科   34 ( 11 )   1296 - 1296   2021.11

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study.

Tomoko Hamaya, Shingo Hatakeyama, Toshikazu Tanaka, Yuka Kubota, Kyo Togashi, Shogo Hosogoe, Naoki Fujita, Ayumu Kusaka, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJU international   128 ( 4 )   468 - 476   2021.10

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study.

Hamaya T, Hatakeyama S, Tanaka T, Kubota Y, Togashi K, Hosogoe S, Fujita N, Kusaka A, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

BJU international   128 ( 4 )   468 - 476   2021.10

Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.

Togashi K, Hatakeyama S, Okamoto T, Kojima Y, Iwamura H, Fujita N, Narita T, Hamano I, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   39 ( 10 )   729.e17 - 729.e25   2021.10

Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.

Kyo Togashi, Shingo Hatakeyama, Teppei Okamoto, Yuta Kojima, Hiromichi Iwamura, Naoki Fujita, Takuma Narita, Itsuto Hamano, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   39 ( 10 )   729.e17-729.e25   2021.10

Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.

Kubota Y, Hatakeyama S, Yoneyama T, Yoneyama MS, Hamano I, Konishi S, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

World journal of urology   39 ( 9 )   3265 - 3271   2021.9

Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancer.

Masaki Shiota, Naoki Terada, Hiroshi Kitamura, Takahiro Kojima, Toshihiro Saito, Akira Yokomizo, Naoki Kohei, Takayuki Goto, Sadafumi Kawamura, Yasuhiro Hashimoto, Atsushi Takahashi, Takahiro Kimura, Ken-Ichi Tabata, Ryotaro Tomida, Kohei Hashimoto, Toshihiko Sakurai, Toru Shimazui, Shinichi Sakamoto, Manabu Kamiyama, Nobumichi Tanaka, Koji Mitsuzuka, Takuma Kato, Shintaro Narita, Hiroaki Yasumoto, Shogo Teraoka, Masashi Kato, Takahiro Osawa, Yoshiyuki Nagumo, Hiroaki Matsumoto, Hideki Enokida, Takayuki Sugiyama, Kentaro Kuroiwa, Takahiro Inoue, Mikio Sugimoto, Takashi Mizowaki, Toshiyuki Kamoto, Hiroyuki Nishiyama, Masatoshi Eto

Cancer science   112 ( 9 )   3616 - 3626   2021.9

Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.

Yuka Kubota, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Itsuto Hamano, Sakae Konishi, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

World journal of urology   39 ( 9 )   3265 - 3271   2021.9

Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study.

Takuma Narita, Shingo Hatakeyama, Kazuyuki Numakura, Mizuki Kobayashi, Yumina Muto, Mitsuru Saito, Shintaro Narita, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Takahiro Yoneyama, Yasuhiro Hashimoto, Tomonori Habuchi, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   28 ( 9 )   899 - 905   2021.9

Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study.

Narita T, Hatakeyama S, Numakura K, Kobayashi M, Muto Y, Saito M, Narita S, Tanaka T, Noro D, Tokui N, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   28 ( 9 )   899 - 905   2021.9

尿路結石形成に関与する糖鎖変異オステオポンチンの検索

阿南 剛, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

日本内分泌学会雑誌   97 ( S.Update )   47 - 49   2021.7

腎臓結石形成に関与する糖鎖変異オステオポンチンの同定

阿南 剛, 米山 徹, 畠山 真吾, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

日本腎臓学会誌   63 ( 4 )   447 - 447   2021.6

転移性腎細胞癌に対する1stライン治療成績の比較検討 ニボルマブ・イピリムマブ併用療法vs.チロシンキナーゼ阻害薬(多施設共同研究)

田中 壽和, 畠山 真吾, 沼倉 一幸, 及川 真亮, 野呂 大輔, 細越 正吾, 成田 伸太郎, 井上 高光, 米山 高弘, 伊藤 弘之, 西村 祥二, 川口 俊明, 橋本 安弘, 羽渕 友則, 大山 力

泌尿器外科   34 ( 臨増 )   793 - 793   2021.6

Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study.

Takuma Narita, Shingo Hatakeyama, Kazuyuki Numakura, Mizuki Kobayashi, Yumina Muto, Mitsuru Saito, Shintaro Narita, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Takahiro Yoneyama, Yasuhiro Hashimoto, Tomonori Habuchi, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   2021.5

ヌーナン症候群患者に施行した献腎移植の一例

小玉 寛健, 畠山 真吾, 村澤 洋美, 杉山 尚樹, 岡本 亜希子, 山本 勇人, 北原 竜次, 米山 高弘, 橋本 安弘, 齋藤 久夫, 大山 力

日本透析医学会雑誌   54 ( Suppl.1 )   463 - 463   2021.5

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.

Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Tadashi Yoshizawa, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama

Urologic oncology   39 ( 4 )   238.e9-238.e17 - 238.e17   2021.4

Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patients.

Masaki Shiota, Naoki Terada, Toshihiro Saito, Akira Yokomizo, Naoki Kohei, Takayuki Goto, Sadafumi Kawamura, Yasuhiro Hashimoto, Atsushi Takahashi, Takahiro Kimura, Ken-Ichi Tabata, Ryotaro Tomida, Kohei Hashimoto, Toshihiko Sakurai, Toru Shimazui, Shinichi Sakamoto, Manabu Kamiyama, Nobumichi Tanaka, Koji Mitsuzuka, Takuma Kato, Shintaro Narita, Hiroaki Yasumoto, Shogo Teraoka, Masashi Kato, Takahiro Osawa, Yoshiyuki Nagumo, Hiroaki Matsumoto, Hideki Enokida, Takayuki Sugiyama, Kentaro Kuroiwa, Takahiro Inoue, Takashi Mizowaki, Toshiyuki Kamoto, Takahiro Kojima, Hiroshi Kitamura, Mikio Sugimoto, Hiroyuki Nishiyama, Masatoshi Eto

Cancer science   112 ( 4 )   1524 - 1533   2021.4

Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.

Yuka Kubota, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Itsuto Hamano, Sakae Konishi, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

World journal of urology   2021.3

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).

Kyo Togashi, Shingo Hatakeyama, Yuta Kojima, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Itsuto Hamano, Tomoko Hamaya, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   39 ( 3 )   192.e7-192.e14 - 192.e14   2021.3

Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).

Hiromichi Iwamura, Shingo Hatakeyama, Masaki Momota, Yuta Kojima, Takuma Narita, Teppei Okamoto, Naoki Fujita, Itsuto Hamano, Kyou Togashi, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Translational andrology and urology   10 ( 3 )   1143 - 1151   2021.3

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.

Fujita N, Hatakeyama S, Okita K, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   39 ( 3 )   191.e9 - 191.e16   2021.3

Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   39 ( 3 )   194.e9-194.e16 - 194.e16   2021.3

Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).

Kodama H, Hatakeyama S, Momota M, Togashi K, Hamaya T, Hamano I, Fujita N, Kojima Y, Okamoto T, Yoneyama T, Yamamoto H, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   39 ( 3 )   191.e1 - 191.e8   2021.3

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   39 ( 3 )   191.e9-191.e16   2021.3

Ghrelin after chemotherapy as a prognostic predictor of progression-free survival in patients with muscle-invasive bladder cancer.

Masayuki Tomioka, Tohru Yoneyama, Yuki Tobisawa, Kota Kawase, Chie Nakai, Manabu Takai, Daiki Kato, Koji Iinuma, Keita Nakane, Kosuke Mizutani, Yasuhiro Hashimoto, Takuya Koie

Translational andrology and urology   10 ( 3 )   1192 - 1201   2021.3

Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).

Hirotake Kodama, Shingo Hatakeyama, Masaki Momota, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Naoki Fujita, Yuta Kojima, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   39 ( 3 )   191.e1-191.e8   2021.3

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study

Tomoko Hamaya, Shingo Hatakeyama, Toshikazu Tanaka, Yuka Kubota, Kyo Togashi, Shogo Hosogoe, Naoki Fujita, Ayumu Kusaka, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJU International   128 ( 4 )   468 - 476   2021.2

Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution.

Takuya Koie, Yasuhiro Hashimoto, Atsushi Imai, Tohru Yoneyama, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Tadashi Suzuki

International urology and nephrology   53 ( 2 )   275 - 280   2021.2

N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.

Kodama H, Yoneyama T, Tanaka T, Noro D, Tobisawa Y, Yamamoto H, Suto S, Hatakeyama S, Mori K, Yoneyama T, Hashimoto Y, Kakizaki I, Nakaji S, Ohyama C

Cancer medicine   10 ( 4 )   1297 - 1313   2021.2

Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution.

Takuya Koie, Yasuhiro Hashimoto, Atsushi Imai, Tohru Yoneyama, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Tadashi Suzuki

International urology and nephrology   53 ( 2 )   275 - 280   2021.2

N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.

Hirotake Kodama, Tohru Yoneyama, Toshikazu Tanaka, Daisuke Noro, Yuki Tobisawa, Hayato Yamamoto, Shinichiro Suto, Shingo Hatakeyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuko Kakizaki, Shigeyuki Nakaji, Chikara Ohyama

Cancer medicine   10 ( 4 )   1297 - 1313   2021.2

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicenter retrospective study.

Tomoko Hamaya, Shingo Hatakeyama, Toshikazu Tanaka, Yuka Kubota, Kyo Togashi, Shogo Hosogoe, Naoki Fujita, Ayumu Kusaka, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJU international   2021.1

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study.

Tomoko Hamaya, Shingo Hatakeyama, Toshikazu Tanaka, Yuka Kubota, Kyo Togashi, Shogo Hosogoe, Naoki Fujita, Ayumu Kusaka, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJU international   2021.1

N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.

Hirotake Kodama, Tohru Yoneyama, Toshikazu Tanaka, Daisuke Noro, Yuki Tobisawa, Hayato Yamamoto, Shinichiro Suto, Shingo Hatakeyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuko Kakizaki, Shigeyuki Nakaji, Chikara Ohyama

Cancer medicine   2021.1

N ‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas

Hirotake Kodama, Tohru Yoneyama, Toshikazu Tanaka, Daisuke Noro, Yuki Tobisawa, Hayato Yamamoto, Shinichiro Suto, Shingo Hatakeyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuko Kakizaki, Shigeyuki Nakaji, Chikara Ohyama

Cancer Medicine   2021.1

N ‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas

Hirotake Kodama, Tohru Yoneyama, Toshikazu Tanaka, Daisuke Noro, Yuki Tobisawa, Hayato Yamamoto, Shinichiro Suto, Shingo Hatakeyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuko Kakizaki, Shigeyuki Nakaji, Chikara Ohyama

Cancer Medicine   10 ( 4 )   1297 - 1313   2021.1

Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.

Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Kazutaka Okita, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Teppei Okamoto, Hiromichi Iwamura, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Lower urinary tract symptoms   13 ( 1 )   56 - 63   2021.1

Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   39 ( 1 )   75.e9 - 75.e16   2021.1

Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study.

Koichi Kido, Shingo Hatakeyama, Kazuyuki Numakura, Toshikazu Tanaka, Masaaki Oikawa, Daisuke Noro, Shogo Hosogoe, Shintaro Narita, Takamitsu Inoue, Takahiro Yoneyama, Hiroyuki Ito, Shoji Nishimura, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama

International journal of clinical oncology   26 ( 1 )   154 - 162   2021.1

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).

Tomoko Hamaya, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Yuta Kojima, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology   26 ( 1 )   199 - 206   2021.1

Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Okita K, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   39 ( 1 )   75.e9 - 75.e16   2021.1

Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study.

Kido K, Hatakeyama S, Numakura K, Tanaka T, Oikawa M, Noro D, Hosogoe S, Narita S, Inoue T, Yoneyama T, Ito H, Nishimura S, Hashimoto Y, Kawaguchi T, Habuchi T, Ohyama C

International journal of clinical oncology   26 ( 1 )   154 - 162   2021.1

Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study.

Koichi Kido, Shingo Hatakeyama, Kazuyuki Numakura, Toshikazu Tanaka, Masaaki Oikawa, Daisuke Noro, Shogo Hosogoe, Shintaro Narita, Takamitsu Inoue, Takahiro Yoneyama, Hiroyuki Ito, Shoji Nishimura, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama

International journal of clinical oncology   26 ( 1 )   154 - 162   2021.1

Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study

Koichi Kido, Shingo Hatakeyama, Kazuyuki Numakura, Toshikazu Tanaka, Masaaki Oikawa, Daisuke Noro, Shogo Hosogoe, Shintaro Narita, Takamitsu Inoue, Takahiro Yoneyama, Hiroyuki Ito, Shoji Nishimura, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama

International Journal of Clinical Oncology   26 ( 1 )   154 - 162   2021.1

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).

Tomoko Hamaya, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Yuta Kojima, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology   26 ( 1 )   199 - 206   2021.1

Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   39 ( 1 )   75.e9-75.e16   2021.1

RARCと回腸を利用した尿路変向術

米山 高弘, 富樫 赳, 堀口 裕貴, 小玉 寛健, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人, 畠山 真吾, 橋本 安弘, 大山 力

Japanese Journal of Endourology   34 ( 1 )   24 - 32   2021

A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.

Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Teppei Okamoto, Kazutaka Okita, Itsuto Hamano, Takuma Narita, Yuta Kojima, Hiromichi Iwamura, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologia internationalis   105 ( 3-4 )   232 - 239   2021

Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study.

Toshikazu Tanaka, Shingo Hatakeyama, Kazuyuki Numakura, Koichi Kido, Daisuke Noro, Masaaki Oikawa, Shogo Hosogoe, Noriko Tokui, Hayato Yamamoto, Shintaro Narita, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   27 ( 12 )   1095 - 1100   2020.12

Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.

Kyo Togashi, Shingo Hatakeyama, Teppei Okamoto, Yuta Kojima, Hiromichi Iwamura, Naoki Fujita, Takuma Narita, Itsuto Hamano, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   2020.12

Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.

Kyo Togashi, Shingo Hatakeyama, Teppei Okamoto, Yuta Kojima, Hiromichi Iwamura, Naoki Fujita, Takuma Narita, Itsuto Hamano, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   2020.12

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.

Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Tadashi Yoshizawa, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama

Urologic oncology   2020.12

A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.

Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Teppei Okamoto, Kazutaka Okita, Itsuto Hamano, Takuma Narita, Yuta Kojima, Hiromichi Iwamura, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologia internationalis   1 - 8   2020.12

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.

Thomas Powles, Michiel S van der Heijden, Daniel Castellano, Matthew D Galsky, Yohann Loriot, Daniel P Petrylak, Osamu Ogawa, Se Hoon Park, Jae-Lyun Lee, Ugo De Giorgi, Martin Bögemann, Aristotelis Bamias, Bernhard J Eigl, Howard Gurney, Som D Mukherjee, Yves Fradet, Iwona Skoneczna, Marinos Tsiatas, Andrey Novikov, Cristina Suárez, André P Fay, Ignacio Duran, Andrea Necchi, Sophie Wildsmith, Philip He, Natasha Angra, Ashok K Gupta, Wendy Levin, Joaquim Bellmunt,

The Lancet. Oncology   21 ( 12 )   1574 - 1588   2020.12

One-surgeon basketing technique for stone extraction during flexible ureteroscopy for urolithiasis: A comparison between novice and expert surgeons.

Go Anan, Kenji Komatsu, Shingo Hatakeyama, Hiromichi Iwamura, Yuki Kohada, Jotaro Mikami, Jun Ito, Yasuhiro Kaiho, Masaki Shimbo, Fumiyasu Endo, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama, Kazunori Hattori, Makoto Sato

International journal of urology : official journal of the Japanese Urological Association   27 ( 12 )   1072 - 1077   2020.12

腫瘍血管内皮を標的にした新規ホウ素中性子捕捉療法による膀胱癌治療法の開発

畠山 真吾, 米山 徹, 米山 美穂子, 山本 勇人, 米山 高弘, 橋本 安弘, 石山 新太郎, 鈴木 実, 大山 力

日本泌尿器科学会総会   108回   885 - 885   2020.12

Whole-body MRIの定量化 転移性前立腺癌の新たな治療戦略の確立

岩村 大径, 伊藤 淳, 海法 康裕, 小羽田 悠貴, 三上 穣太郎, 阿南 剛, 畠山 真吾, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

日本泌尿器科学会総会   108回   480 - 480   2020.12

尿路結石の発生と予防に対する基礎研究の進歩 尿路結石と糖鎖 オステオポンチン糖鎖変異の検索

阿南 剛, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

日本泌尿器科学会総会   108回   283 - 283   2020.12

One-surgeon basketing technique for stone extraction during flexible ureteroscopy for urolithiasis: A comparison between novice and expert surgeons.

Anan G, Komatsu K, Hatakeyama S, Iwamura H, Kohada Y, Mikami J, Ito J, Kaiho Y, Shimbo M, Endo F, Yoneyama T, Hashimoto Y, Ohyama C, Hattori K, Sato M

International journal of urology : official journal of the Japanese Urological Association   27 ( 12 )   1072 - 1077   2020.12

One-surgeon basketing technique for stone extraction during flexible ureteroscopy for urolithiasis: A comparison between novice and expert surgeons.

Go Anan, Kenji Komatsu, Shingo Hatakeyama, Hiromichi Iwamura, Yuki Kohada, Jotaro Mikami, Jun Ito, Yasuhiro Kaiho, Masaki Shimbo, Fumiyasu Endo, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama, Kazunori Hattori, Makoto Sato

International journal of urology : official journal of the Japanese Urological Association   27 ( 12 )   1072 - 1077   2020.12

1st-line Axitinib療法におけるIMDCリスク分類の有用性についての検討

小西 栄, 畠山 真吾, 沼倉 一幸, 成田 伸太郎, 井上 高光, 齋藤 満, 米山 高弘, 橋本 安弘, 吉川 和暁, 成田 知, 川口 俊明, 羽渕 友則, 大山 力

日本泌尿器科学会総会   108回   1416 - 1416   2020.12

Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patients.

Masaki Shiota, Naoki Terada, Toshihiro Saito, Akira Yokomizo, Naoki Kohei, Takayuki Goto, Sadafumi Kawamura, Yasuhiro Hashimoto, Atsushi Takahashi, Takahiro Kimura, Ken-Ichi Tabata, Ryotaro Tomida, Kohei Hashimoto, Toshihiko Sakurai, Toru Shimazui, Shinichi Sakamoto, Manabu Kamiyama, Nobumichi Tanaka, Koji Mitsuzuka, Takuma Kato, Shintaro Narita, Hiroaki Yasumoto, Shogo Teraoka, Masashi Kato, Takahiro Osawa, Yoshiyuki Nagumo, Hiroaki Matsumoto, Hideki Enokida, Takayuki Sugiyama, Kentaro Kuroiwa, Takahiro Inoue, Takashi Mizowaki, Toshiyuki Kamoto, Takahiro Kojima, Hiroshi Kitamura, Mikio Sugimoto, Hiroyuki Nishiyama, Masatoshi Eto,

Cancer science   2020.11

Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer.

Naoki Terada, Takashi Mizowaki, Toshihiro Saito, Akira Yokomizo, Naoki Kohei, Ken-Ichi Tabata, Masaki Shiota, Atsushi Takahashi, Toru Shimazui, Takayuki Goto, Yasuhiro Hashimoto, Masato Fujii, Ryotaro Tomida, Toshihiko Sakurai, Kohei Hashimoto, Sadafumi Kawamura, Shogo Teraoka, Shinichi Sakamoto, Takahiro Kimura, Manabu Kamiyama, Shintaro Narita, Nobumichi Tanaka, Takuma Kato, Masashi Kato, Takahiro Osawa, Takahiro Kojima, Takahiro Inoue, Mikio Sugimoto, Hiroyuki Nishiyama, Toshiyuki Kamoto

BJUI compass   1 ( 5 )   165 - 173   2020.11

Continued smoking and posterior vitreous adhesion in the elderly evaluated on swept-source optical coherence tomography.

Toyama T, Hashimoto Y, Kawai H, Azuma K, Shiraya T, Araki F, Sugimoto K, Watanabe Y, Hirano H, Fujiwara Y, Ihara K, Kim H, Kato S, Numaga J, Obuchi S, Ueta T

Scientific reports   10 ( 1 )   18460   2020.10

Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Yasushi Mariya, Chikara Ohyama

Clinical genitourinary cancer   18 ( 5 )   e523 - e530   2020.10

Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   38 ( 10 )   795.e9 - 795.e17   2020.10

尿路結石形成に関与する糖鎖変異オステオポンチンの検索

阿南 剛, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 伊藤 淳, 海法 康裕, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

日本内分泌学会雑誌   96 ( 2 )   528 - 528   2020.10

転移性腎細胞癌の一次治療におけるニボルマブ・イピリムマブ併用療法とTKIの比較検討

細越 正吾, 畠山 真吾, 沼倉 一幸, 田中 壽和, 及川 真亮, 野呂 大輔, 成田 伸太郎, 井上 高光, 米山 高弘, 伊藤 弘之, 西村 祥二, 川口 俊明, 橋本 安弘, 羽渕 友則, 大山 力

日本癌治療学会学術集会抄録集   58回   P - 289   2020.10

マージナルドナーからの生体腎移植における移植成績ならびにドナー・レシピエント腎機能の検討

濱野 逸人, 畠山 真吾, 濱谷 智子, 百田 匡毅, 成田 拓磨, 小島 由太, 岩村 大径, 米山 徹, 岡本 哲平, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力

移植   55 ( 総会臨時 )   356 - 356   2020.10

ヌーナン症候群患者に施行した献腎移植

小玉 寛健, 畠山 真吾, 村澤 洋美, 杉山 尚樹, 岡本 亜希子, 山本 勇人, 北原 竜次, 米山 高弘, 橋本 安弘, 齋藤 久夫, 大山 力

移植   55 ( 総会臨時 )   365 - 365   2020.10

Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   2020.9

Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study.

Toshikazu Tanaka, Shingo Hatakeyama, Kazuyuki Numakura, Koichi Kido, Daisuke Noro, Masaaki Oikawa, Shogo Hosogoe, Noriko Tokui, Hayato Yamamoto, Shintaro Narita, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   27 ( 12 )   1095 - 1100   2020.9

経尿道的尿管砕石術における1人抽石法の有効性と安全性 レーザー使用量を抑え尿路損傷を減らす取り組み

阿南 剛, 畠山 真吾, 小羽田 悠貴, 三上 穣太郎, 伊藤 淳, 海法 康裕, 米山 高弘, 橋本 安弘, 大山 力, 佐藤 信

日本レーザー医学会誌   41 ( 3 )   261 - 261   2020.9

Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.

Kazutaka Okita, Shingo Hatakeyama, Masaki Momota, Osamu Soma, Itsuto Hamano, Toshikazu Tanaka, Hiromichi Iwamura, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   27 ( 8 )   649 - 654   2020.8

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).

Kyo Togashi, Shingo Hatakeyama, Yuta Kojima, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Itsuto Hamano, Tomoko Hamaya, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   2020.8

One‐surgeon basketing technique for stone extraction during flexible ureteroscopy for urolithiasis: A comparison between novice and expert surgeons

Go Anan, Kenji Komatsu, Shingo Hatakeyama, Hiromichi Iwamura, Yuki Kohada, Jotaro Mikami, Jun Ito, Yasuhiro Kaiho, Masaki Shimbo, Fumiyasu Endo, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama, Kazunori Hattori, Makoto Sato

International Journal of Urology   27 ( 12 )   1072 - 1077   2020.8

One-surgeon basketing technique for stone extraction during flexible ureteroscopy for urolithiasis: A comparison between novice and expert surgeons.

Go Anan, Kenji Komatsu, Shingo Hatakeyama, Hiromichi Iwamura, Yuki Kohada, Jotaro Mikami, Jun Ito, Yasuhiro Kaiho, Masaki Shimbo, Fumiyasu Endo, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama, Kazunori Hattori, Makoto Sato

International journal of urology : official journal of the Japanese Urological Association   2020.8

Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   38 ( 8 )   684.e1 - 684.e8   2020.8

Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Koichi Kido, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   38 ( 8 )   684.e17 - 684.e24   2020.8

The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

International urology and nephrology   52 ( 8 )   1421 - 1428   2020.8

Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Koichi Kido, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   38 ( 8 )   684.e17-684.e24 - 684.e24   2020.8

Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   38 ( 8 )   684.e1-684.e8 - 684.e8   2020.8

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   2020.7

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   39 ( 3 )   191.e9-191.e16   2020.7

Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).

Hirotake Kodama, Shingo Hatakeyama, Masaki Momota, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Naoki Fujita, Yuta Kojima, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   2020.7

Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).

Hirotake Kodama, Shingo Hatakeyama, Masaki Momota, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Naoki Fujita, Yuta Kojima, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   39 ( 3 )   191.e1-191.e8   2020.7

Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   39 ( 1 )   75.e9-75.e16   2020.7

Survey on attitudes toward brain-dead and living donor transplantation in medical students: a cross-sectional study in Japan.

Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama

Clinical and experimental nephrology   24 ( 7 )   638 - 645   2020.7

Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.

Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

IJU case reports   3 ( 4 )   141 - 144   2020.7

Survey on attitudes toward brain-dead and living donor transplantation in medical students: a cross-sectional study in Japan.

Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama

Clinical and experimental nephrology   24 ( 7 )   638 - 645   2020.7

Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal Function

Itsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, Reiichi Murakami, Tomoko Hamaya, Kyo Togashi, Yuichiro Suzuki, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama

Transplantation Proceedings   52 ( 6 )   1723 - 1728   2020.7

Outcome of ABO Blood Type–Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan

Itsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, Reiichi Murakami, Tomoko Hamaya, Kyo Togashi, Yuichiro Suzuki, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama

Transplantation Proceedings   52 ( 6 )   1700 - 1704   2020.7

Frailty is a predictor of moderate to severe pain after robot-assisted laparoscopic prostatectomy: A case-control study (FRAP study).

Momota M, Hatakeyama S, Soma O, Hamano I, Fujita N, Okamoto T, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

BJUI compass   1 ( 3 )   100 - 107   2020.7

Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.

Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

IJU case reports   3 ( 4 )   141 - 144   2020.6

Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan

Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Kazutaka Okita, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Teppei Okamoto, Hiromichi Iwamura, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

LUTS: Lower Urinary Tract Symptoms   13 ( 1 )   56 - 63   2020.6

Geriatric 8 screening of frailty in patients with prostate cancer.

Masaki Momota, Shingo Hatakeyama, Osamu Soma, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   27 ( 8 )   642 - 648   2020.6

The impact of microalbuminuria on overactive bladders: Results from a community-based four-year longitudinal study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Masataka Ando, Jung Songee, Atsushi Imai, Itsuto Hamano, Naoki Fujita, Akiko Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Neurourology and urodynamics   39 ( 5 )   1567 - 1575   2020.6

尿路結石バイオマーカーとして尿中糖鎖変異オステオポンチン(PolyLacNAc-OPN)の同定

阿南 剛, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 伊藤 淳, 海法 康裕, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

泌尿器科紀要   66 ( 6 )   180 - 180   2020.6

一般住民健診における、高齢女性の過活動膀胱と、抗酸化物質との関連について(岩木町健康増進プロジェクトにおける調査)

今井 篤, 山木 勇人, 畠山 真吾, 米山 高弘, 橋本 安弘, 大山 力, 沢田 かほり, 中路 重之

泌尿器外科   33 ( 臨増 )   913 - 913   2020.6

The impact of microalbuminuria on overactive bladders: Results from a community-based four-year longitudinal study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Masataka Ando, Jung Songee, Atsushi Imai, Itsuto Hamano, Naoki Fujita, Akiko Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Neurourology and urodynamics   39 ( 5 )   1567 - 1575   2020.5

Frailty is significantly associated with the type of urinary diversion in patients with muscle‐invasive bladder cancer

Kazutaka Okita, Shingo Hatakeyama, Masaki Momota, Osamu Soma, Itsuto Hamano, Toshikazu Tanaka, Hiromichi Iwamura, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

International Journal of Urology   27 ( 8 )   649 - 654   2020.5

Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal Function.

Itsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, Reiichi Murakami, Tomoko Hamaya, Kyo Togashi, Yuichiro Suzuki, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama

Transplantation proceedings   52 ( 6 )   1723 - 1728   2020.5

Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.

Itsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, Reiichi Murakami, Tomoko Hamaya, Kyo Togashi, Yuichiro Suzuki, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama

Transplantation proceedings   52 ( 6 )   1700 - 1704   2020.5

Altered gut microbiome associated with overactive bladder and daily urinary urgency.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

World journal of urology   2020.5

Altered gut microbiome associated with overactive bladder and daily urinary urgency.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

World journal of urology   39 ( 3 )   847 - 853   2020.5

Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   38 ( 10 )   795.e9-795.e17 - 795.e17   2020.5

Geriatric 8 screening of frailty in patients with prostate cancer.

Masaki Momota, Shingo Hatakeyama, Osamu Soma, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   27 ( 8 )   642 - 648   2020.4

STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasis.

Kazutaka Okita, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Itsuto Hamano, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   27 ( 4 )   344 - 349   2020.4

Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.

Hirotake Kodama, Takuya Koie, Masaaki Oikawa, Takuma Narita, Toshikazu Tanaka, Daisuke Noro, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International urology and nephrology   52 ( 4 )   671 - 679   2020.4

The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

World journal of urology   2020.3

The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

International urology and nephrology   2020.3

The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

World journal of urology   39 ( 1 )   169 - 175   2020.3

Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Yasushi Mariya, Chikara Ohyama

Clinical genitourinary cancer   18 ( 5 )   e523-e530 - e530   2020.3

STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasis.

Kazutaka Okita, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Itsuto Hamano, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   2020.3

Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.

Sappaya Suppanuntaroek, Shingo Hatakeyama, Naoki Fujita, Yuka Kubota, Yuichiro Suzuki, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Kazuyuki Mori, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology   25 ( 2 )   362 - 369   2020.2

Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.

Sappaya Suppanuntaroek, Shingo Hatakeyama, Naoki Fujita, Yuka Kubota, Yuichiro Suzuki, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Kazuyuki Mori, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology   25 ( 2 )   362 - 369   2020.2

Impact of the Proportion of Biopsy Positive Core in Predicting Biochemical Recurrence in Patients with Pathological Pt2 and Negative Resection Margin Status after Radical Prostatectomy.

Masaaki Oikawa, Toshikazu Tanaka, Takuma Narita, Daisuke Noro, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Hirotake Kodama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Pathology oncology research : POR   2020.1

Impact of the Proportion of Biopsy Positive Core in Predicting Biochemical Recurrence in Patients with Pathological Pt2 and Negative Resection Margin Status after Radical Prostatectomy.

Masaaki Oikawa, Toshikazu Tanaka, Takuma Narita, Daisuke Noro, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Hirotake Kodama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Pathology oncology research : POR   26 ( 4 )   2115 - 2121   2020.1

Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.

Hirotake Kodama, Takuya Koie, Masaaki Oikawa, Takuma Narita, Toshikazu Tanaka, Daisuke Noro, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International urology and nephrology   2020.1

Leptomeningeal Metastases in a Patient with Castration-Resistant Prostate Cancer.

Takuya Koie, Yasuhiro Hashimoto, Yuichiro Suzuki, Yoshiomi Hatayama, Futoshi Kimura

Case reports in urology   2020   5627548 - 5627548   2020

当科におけるABO不適合移植の移植成績

濱谷 智子, 濱野 逸人, 畠山 真吾, 藤田 雄, 村上 礼一, 岡本 哲平, 鈴木 裕一朗, 山本 勇人, 米山 徹, 米山 高弘, 橋本 安弘, 齋藤 久夫, 鈴木 唯司, 大山 力

移植   55 ( Supplement )   360_1 - 360_1   2020

ヌーナン症候群患者に施行した献腎移植

小玉 寛健, 畠山 真吾, 村澤 洋美, 杉山 尚樹, 岡本 亜希子, 山本 勇人, 北原 竜次, 米山 高弘, 橋本 安弘, 齋藤 久夫, 大山 力

移植   55 ( Supplement )   365_1 - 365_1   2020

ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘術 (RARP) の治療成績

米山 高弘, 濱谷 智子, 百田 匡毅, 濱野 逸人, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人, 今井 篤, 畠山 真吾, 橋本 安弘, 大山 力

Japanese Journal of Endourology   33 ( 2 )   325 - 329   2020

マージナルドナーからの生体腎移植における移植成績ならびにドナー・レシピエント腎機能の検討

濱野 逸人, 畠山 真吾, 濱谷 智子, 百田 匡毅, 成田 拓磨, 小島 由太, 岩村 大径, 米山 徹, 岡本 哲平, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力

移植   55 ( Supplement )   356_1 - 356_1   2020

Leptomeningeal Metastases in a Patient with Castration-Resistant Prostate Cancer.

Takuya Koie, Yasuhiro Hashimoto, Yuichiro Suzuki, Yoshiomi Hatayama, Futoshi Kimura

Case reports in urology   2020   5627548 - 5627548   2020

Posterior vitreous detachment and macular microvasculature in the elderly.

Toyama T, Kawai H, Shiraya T, Araki F, Sugimoto K, Hashimoto Y, Kato S, Numaga J, Watanabe Y, Hirano H, Fujiwara Y, Ihara K, Kim H, Obuchi S, Ueta T

PloS one   15 ( 4 )   e0231351   2020

The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.

Go Anan, Tohru Yoneyama, Daisuke Noro, Yuki Tobisawa, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiromichi Iwamura, Yuki Kohada, Jotaro Mikami, Jun Ito, Yasuhiro Kaiho, Takahiro Yoneyama, Yasuhiro Hashimoto, Makoto Sato, Chikara Ohyama

International journal of molecular sciences   21 ( 1 )   2019.12

The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.

Go Anan, Tohru Yoneyama, Daisuke Noro, Yuki Tobisawa, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiromichi Iwamura, Yuki Kohada, Jotaro Mikami, Jun Ito, Yasuhiro Kaiho, Takahiro Yoneyama, Yasuhiro Hashimoto, Makoto Sato, Chikara Ohyama

International journal of molecular sciences   21 ( 1 )   2019.12

The Relationship Between Gait Function and Erectile Dysfunction: Results from a Community-Based Cross-Sectional Study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

The journal of sexual medicine   16 ( 12 )   1922 - 1929   2019.12

The Relationship Between Gait Function and Erectile Dysfunction: Results from a Community-Based Cross-Sectional Study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

The journal of sexual medicine   16 ( 12 )   1922 - 1929   2019.12

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer.

Teppei Matsumoto, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hiroyuki Ito, Shin-Ichiro Nishimura, Chikara Ohyama

Scientific reports   9 ( 1 )   16761 - 16761   2019.11

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer.

Teppei Matsumoto, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hiroyuki Ito, Shin-Ichiro Nishimura, Chikara Ohyama

Scientific reports   9 ( 1 )   16761 - 16761   2019.11

Bilateral scrotal mass mimicking testicular cancer: An unusual presentation of sarcoidosis.

Sakae Konishi, Shingo Hatakeyama, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   26 ( 11 )   1079 - 1081   2019.11

The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.

Masaki Momota, Shingo Hatakeyama, Noriko Tokui, Tendo Sato, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Satoshi Narita, Toshiaki Kawaguchi, Chikara Ohyama

European urology focus   5 ( 6 )   1066 - 1073   2019.11

Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.

Koichi Kido, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

European urology focus   5 ( 6 )   1120 - 1126   2019.11

Bilateral scrotal mass mimicking testicular cancer: An unusual presentation of sarcoidosis.

Sakae Konishi, Shingo Hatakeyama, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   26 ( 11 )   1079 - 1081   2019.11

Development of Quality Indicators of Stroke Centers and Feasibility of Their Measurement Using a Nationwide Insurance Claims Database in Japan　― J-ASPECT Study ―.

Nishimura A, Nishimura K, Onozuka D, Matsuo R, Kada A, Kamitani S, Higashi T, Ogasawara K, Shimodozono M, Harada M, Hashimoto Y, Hirano T, Hoshino H, Itabashi R, Itoh Y, Iwama T, Kohriyama T, Matsumaru Y, Osato T, Sasaki M, Shiokawa Y, Shimizu H, Takekawa H, Nishi T, Uno M, Yagita Y, Ido K, Kurogi A, Kurogi R, Arimura K, Ren N, Hagihara A, Takizawa S, Arai H, Kitazono T, Miyamoto S, Minematsu K, Iihara K, J-ASPECT study collaborators

Circulation journal : official journal of the Japanese Circulation Society   83 ( 11 )   2292 - 2302   2019.10

Relationship between frailty and lower urinary tract symptoms among community-dwelling adults.

Osamu Soma, Shingo Hatakeyama, Atsushi Imai, Teppei Matsumoto, Itsuto Hamano, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

Lower urinary tract symptoms   2019.10

Relationship between frailty and lower urinary tract symptoms among community-dwelling adults.

Osamu Soma, Shingo Hatakeyama, Atsushi Imai, Teppei Matsumoto, Itsuto Hamano, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

Lower urinary tract symptoms   12 ( 2 )   128 - 136   2019.10

C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma.

Sakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   26 ( 10 )   992 - 998   2019.10

Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study.

Sakae Konishi, Shingo Hatakeyama, Kazuyuki Numakura, Shintaro Narita, Takamitsu Inoue, Mitsuru Saito, Noriko Tokui, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Satoshi Narita, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama

Clinical genitourinary cancer   17 ( 5 )   e1080-e1089 - e1089   2019.10

第一選択アキシチニブで治療した転移性腎細胞癌患者におけるIMDC予後モデルの検証

小西 栄, 畠山 真吾, 沼倉 一幸, 成田 伸太郎, 井上 高光, 齋藤 満, 得居 範子, 山本 勇人, 米山 高弘, 橋本 安弘, 吉川 和暁, 成田 智, 川口 俊明, 羽渕 友則, 大山 力

日本癌治療学会学術集会抄録集   57回   O45 - 3   2019.10

Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.

Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Itsuto Hamano, Toshikazu Tanaka, Masaki Momota, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Hisao Saitoh, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama

Medical oncology (Northwood, London, England)   36 ( 10 )   88 - 88   2019.9

Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.

Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Itsuto Hamano, Toshikazu Tanaka, Masaki Momota, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Hisao Saitoh, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama

Medical oncology (Northwood, London, England)   36 ( 10 )   88 - 88   2019.9

弘前大学腎移植チームによる腎移植の成績

米山 高弘, 鈴木 裕一朗, 米山 徹, 盛 和行, 山本 勇人, 藤田 雄, 今井 篤, 村上 礼一, 畠山 真吾, 橋本 安弘, 斉藤 久夫, 中村 典雄, 鳴海 俊治, 鈴木 唯司, 大山 力

移植   54 ( 総会臨時 )   327 - 327   2019.9

抗HLA抗体検査保険収載に伴う院内体制の整備経験

盛 和行, 村上 礼一, 藤田 雄, 石戸 圭之輔, 山本 勇人, 今井 篤, 畠山 真吾, 橋本 安弘, 米山 高弘, 大山 力

MHC: Major Histocompatibility Complex   26 ( 2Suppl. )   127 - 127   2019.9

Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection.

Tohru Yoneyama, Yuki Tobisawa, Tomonori Kaneko, Takatoshi Kaya, Shingo Hatakeyama, Kazuyuki Mori, Mihoko Sutoh Yoneyama, Teppei Okubo, Koji Mitsuzuka, Wilhelmina Duivenvoorden, Jehonathan H Pinthus, Yasuhiro Hashimoto, Akihiro Ito, Takuya Koie, Yoshihiko Suda, Robert A Gardiner, Chikara Ohyama

Cancer science   110 ( 8 )   2573 - 2589   2019.8

C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma.

Sakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   26 ( 10 )   992 - 998   2019.7

Robot-assisted radical cystectomy in a patient with muscle-invasive bladder cancer following radiotherapy for prostate cancer.

Kubota Y, Hatakeyama S, Hashimoto T, Fujita N, Okamoto T, Suzuki Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

IJU case reports   2 ( 4 )   236 - 239   2019.7

Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection.

Tohru Yoneyama, Yuki Tobisawa, Tomonori Kaneko, Takatoshi Kaya, Shingo Hatakeyama, Kazuyuki Mori, Mihoko Sutoh Yoneyama, Teppei Okubo, Koji Mitsuzuka, Wilhelmina Duivenvoorden, Jehonathan H Pinthus, Yasuhiro Hashimoto, Akihiro Ito, Takuya Koie, Yoshihiko Suda, Robert A Gardiner, Chikara Ohyama

Cancer science   110 ( 8 )   2573 - 2589   2019.6

Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study.

Sakae Konishi, Shingo Hatakeyama, Kazuyuki Numakura, Shintaro Narita, Takamitsu Inoue, Mitsuru Saito, Noriko Tokui, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Satoshi Narita, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama

Clinical genitourinary cancer   17 ( 5 )   e1080 - e1089   2019.6

筋層浸潤膀胱癌に対する術前化学療法の抗腫瘍効果

阿南 剛, 畠山 真吾, 藤田 尚紀, 岩村 大径, 米山 高弘, 橋本 安弘, 古家 琢也, 伊藤 弘之, 吉川 和暁, 川口 俊明, 佐藤 信, 大山 力

泌尿器科紀要   65 ( 6 )   248 - 249   2019.6

Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.

Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shunji Narumi, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama

Clinical and experimental nephrology   23 ( 6 )   807 - 813   2019.6

Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.

Kazutaka Okita, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Naoki Fujita, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

Clinical genitourinary cancer   17 ( 3 )   e440-e446 - e446   2019.6

一般住民健診における女性の過活動膀胱の重症度とリスク因子についての検討

今井 篤, 山本 勇人, 畠山 真吾, 米山 高弘, 橋本 安弘, 大山 力, 沢田 かほり, 中路 重之

泌尿器外科   32 ( 臨増 )   749 - 749   2019.6

Renal cell carcinoma in a lumbar ectopic kidney.

Hamano I, Hatakeyama S, Soma O, Ishibashi Y, Yoneyama T, Yoneyama T, Hashimoto Y, Nishimura S, Koie T, Ohyama C

IJU case reports   2 ( 3 )   124 - 127   2019.5

75歳以上の高齢者に対するロボット支援前立腺全摘除術の治療成績

米山 高弘, 相馬 理, 松本 哲平, 米山 徹, 鈴木 裕一朗, 山本 勇人, 今井 篤, 畠山 真吾, 橋本 安弘, 大山 力

日本老年泌尿器科学会誌   32 ( 1 )   193 - 193   2019.5

一般住民健診における男性の排尿症状と液性物質との関連について

今井 篤, 山本 勇人, 畠山 真吾, 米山 高弘, 橋本 安弘, 大山 力, 沢田 かほり, 中路 重之

日本老年泌尿器科学会誌   32 ( 1 )   170 - 170   2019.5

術前の慢性腎臓病は筋層浸潤膀胱癌・上部尿路上皮癌患者の予後不良因子である

百田 匡毅, 畠山 真吾, 得居 範子, 佐藤 天童, 山本 勇人, 飛澤 悠葵, 米山 徹, 米山 高弘, 橋本 安弘, 古家 琢也, 成田 知, 川口 俊明, 大山 力

日本泌尿器科学会総会   107回   AOP - 072   2019.4

ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘除術の治療成績

米山 高弘, 沖田 和貴, 小西 栄, 相馬 理, 松本 哲平, 藤田 尚紀, 米山 徹, 盛 和行, 山本 勇人, 今井 篤, 畠山 真吾, 橋本 安弘, 大山 力

日本泌尿器科学会総会   107回   OP - 296   2019.4

上部尿路上皮内癌(CIS)に対するbacillus Calmette-Guerin(BCG)療法の治療成績 根治的腎尿管全摘術(RNU)との比較

堀口 裕貴, 米山 高弘, 畠山 真吾, 得居 範子, 山本 勇人, 飛澤 悠葵, 米山 徹, 橋本 安弘, 古家 琢也, 吉川 和暁, 成田 知, 川口 俊明, 大山 力

日本泌尿器科学会総会   107回   PP3 - 288   2019.4

下部尿路症状と酸化ストレスの関係 最終糖化産物(AGEs)と8-OHdGの比較

松本 哲平, 山本 勇人, 今井 篤, 米山 徹, 畠山 真吾, 米山 高弘, 橋本 安弘, 中路 重之, 大山 力

日本泌尿器科学会総会   107回   AOP - 060   2019.4

尿路結石形成に関与する尿中糖鎖変異オステオポンチン(PolyLac-OPN)のバイオマーカーの可能性

阿南 剛, 米山 徹, 畠山 真吾, 飛澤 悠葵, 米山 美穂子, 岩村 大径, 伊藤 淳, 海法 康裕, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 鈴木 唯司, 佐藤 信, 大山 力

日本内分泌学会雑誌   95 ( 1 )   379 - 379   2019.4

尿路結石形成に関与する尿中糖鎖変異オステオポンチン(PolyLac-OPN)のバイオマーカーの可能性

阿南 剛, 米山 徹, 畠山 真吾, 飛澤 悠葵, 米山 美穂子, 岩村 大径, 伊藤 淳, 海法 康裕, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 鈴木 唯司, 佐藤 信, 大山 力

日本内分泌学会雑誌   95 ( 1 )   352 - 352   2019.4

急性腎障害は敗血症を伴う尿路感染症患者において予後・脳心血管イベント・腎機能悪化のリスク因子である

藤田 尚紀, 飛澤 悠葵, 米山 徹, 山本 勇人, 今井 篤, 畠山 真吾, 米山 高弘, 伊藤 弘之, 橋本 安弘, 吉川 和暁, 大山 力

日本泌尿器科学会総会   107回   AOP - 040   2019.4

血清N結合型糖鎖変異プロファイルは生体腎移植後の拒絶反応の予測因子として有用である

相馬 理, 畠山 真吾, 米山 徹, 米山 高弘, 橋本 安弘, 佐々木 秀郎, 齋藤 満, 原田 浩, 力石 辰也, 石田 英樹, 田邉 一成, 佐藤 滋, 大山 力

日本泌尿器科学会総会   107回   OP - 008   2019.4

BCG生菌耐性細胞株の遺伝子発現を指標としたドラッグリポジショニング(第一報)

盛 和行, 米山 徹, 山本 勇人, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 大山 力

泌尿器外科   32 ( 4 )   392 - 393   2019.4

尿路結石形成に関与する尿中オステオポンチンの糖鎖変異

阿南 剛, 米山 徹, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 古家 琢也, 鈴木 唯司, 佐藤 信, 大山 力

日本尿路結石症学会誌   17 ( 2 )   117 - 119   2019.3

Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.

Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shunji Narumi, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama

Clinical and experimental nephrology   2019.2

Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter study.

Teppei Matsumoto, Shingo Hatakeyama, Takuma Narita, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   2019.1

Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter study.

Teppei Matsumoto, Shingo Hatakeyama, Takuma Narita, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   26 ( 4 )   522 - 523   2019.1

Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.

Kazutaka Okita, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Naoki Fujita, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

Clinical genitourinary cancer   2019.1

MIBGシンチ陽性であった副腎癌の1例

得居 範子, 日下 歩, 細越 正吾, 山本 勇人, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   32 ( 1 )   94 - 94   2019.1

Intermediate risk前立腺癌における、前立腺組織内アンドロゲン濃度とPSA再発の検討

日下 歩, 畠山 真吾, 小玉 寛健, 細越 正吾, 得居 範子, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   32 ( 1 )   93 - 93   2019.1

Robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer: Initial experience and functional outcomes.

Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, Hirotaka Nagasaka, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto

The international journal of medical robotics + computer assisted surgery : MRCAS   14 ( 6 )   e1955 - e1955   2018.12

Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

European urology focus   4 ( 6 )   946 - 953   2018.12

Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.

Kazutaka Okita, Shingo Hatakeyama, Naoki Fujita, Sakae Konishi, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Hiroyuki Ito, Kazuaki Yoshikawa, Takuya Koie, Chikara Ohyama

Medical oncology (Northwood, London, England)   36 ( 1 )   7 - 7   2018.11

Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.

Kazutaka Okita, Shingo Hatakeyama, Naoki Fujita, Sakae Konishi, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Hiroyuki Ito, Kazuaki Yoshikawa, Takuya Koie, Chikara Ohyama

Medical oncology (Northwood, London, England)   36 ( 1 )   7 - 7   2018.11

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.

Sakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Naoki Fujita, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

Medical oncology (Northwood, London, England)   36 ( 1 )   6 - 6   2018.11

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.

Sakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Naoki Fujita, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

Medical oncology (Northwood, London, England)   36 ( 1 )   6 - 6   2018.11

Clinical impact of glomerular basement membrane thickness on post-donation renal function in living donors.

Yuka Kubota, Shingo Hatakeyama, Ikuyo Narita, Michiko Shimada, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   26 ( 2 )   309 - 311   2018.11

Clinical impact of glomerular basement membrane thickness on post-donation renal function in living donors.

Yuka Kubota, Shingo Hatakeyama, Ikuyo Narita, Michiko Shimada, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   26 ( 2 )   309 - 311   2018.11

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.

Naoki Fujita, Takuya Koie, Yasuhiro Hashimoto, Takuma Narita, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Kazuhisa Hagiwara, Tohru Yoneyama, Atsushi Imai, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Chikara Ohyama

International urology and nephrology   50 ( 11 )   1999 - 2005   2018.11

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.

Naoki Fujita, Takuya Koie, Yasuhiro Hashimoto, Takuma Narita, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Kazuhisa Hagiwara, Tohru Yoneyama, Atsushi Imai, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Chikara Ohyama

International urology and nephrology   50 ( 11 )   1999 - 2005   2018.11

75歳以上高齢者の進行性膀胱癌に対するCarboplatinをベースとした化学療法の治療成績

米山 高弘, 得居 範子, 山本 勇人, 米山 徹, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本老年泌尿器科学会誌   31   117 - 117   2018.11

Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.

Teppei Matsumoto, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Kazuhisa Hagiwara, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

BJU international   123 ( 5 )   877 - 884   2018.10

Condyloma Acuminata of the Urethra in a Male Renal Transplant Recipient: A Case Report.

I Hamano, S Hatakeyama, H Yamamoto, T Fujita, R Murakami, M Shimada, A Imai, T Yoneyama, T Yoneyama, Y Hashimoto, T Koie, S Narumi, H Saitoh, T Suzuki, H Tomita, C Ohyama

Transplantation proceedings   50 ( 8 )   2553 - 2557   2018.10

進行性上部尿路上皮癌における化学療法の予後因子としてのコリンエステラーゼ値の検討

米山 高弘, 松本 哲平, 細越 正吾, 久保田 優花, 日下 歩, 得居 範子, 米山 徹, 盛 和行, 山本 勇人, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本癌治療学会学術集会抄録集   56回   P36 - 4   2018.10

泌尿器科腫瘍に対する分子マーカー研究の現状と将来(Liquid Biopsyを含めて) 泌尿器腫瘍に対する糖鎖バイオマーカーの現状と将来

米山 徹, 石川 友一, 金子 智典, 彼谷 高敏, 飛澤 悠葵, 畠山 真吾, 田中 壽一, 石橋 祐介, 萩原 和久, 橋本 安弘, 古家 琢也, 伊達 睦廣, 須田 美彦, 大山 力

日本癌治療学会学術集会抄録集   56回   PD14 - 1   2018.10

Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.

Teppei Matsumoto, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Kazuhisa Hagiwara, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

BJU international   2018.9

Robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer: Initial experience and functional outcomes.

Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, Hirotaka Nagasaka, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto

The international journal of medical robotics + computer assisted surgery : MRCAS   14 ( 6 )   e1955   2018.9

弘前大学における生体腎移植術への取り組み

米山 高弘, 久保田 優花, 松本 哲平, 細越 正吾, 得居 範子, 米山 徹, 盛 和行, 藤田 雄, 村上 礼一, 山本 勇人, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 鳴海 俊治, 大山 力

移植   53 ( 総会臨時 )   455 - 455   2018.9

尿路結石形成に関与する尿中オステオポンチンの糖鎖変異

阿南 剛, 米山 徹, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 古家 琢也, 鈴木 唯司, 佐藤 信, 大山 力

日本尿路結石症学会誌   17 ( 1 )   46 - 46   2018.8

PSA glycoisoform(PSA-Gi)と既存PSA検査による前立腺癌の診断能の比較

米山 徹, 飛澤 悠葵, 金子 智典, 彼谷 高敏, 畠山 真吾, 今井 篤, 米山 高弘, 橋本 安弘, 古家 琢也, 須田 美彦, 大山 力

泌尿器外科   31 ( 8 )   1179 - 1182   2018.8

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Koichi Kido, Shingo Hatakeyama, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama

International journal of clinical oncology   23 ( 4 )   726 - 733   2018.8

Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.

Itsuto Hamano, Shingo Hatakeyama, Rika Nakamura, Rie Fukuhara, Daisuke Noro, Toshikazu Tanaka, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yoshihito Yokoyama, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   25 ( 9 )   817 - 824   2018.7

Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.

Itsuto Hamano, Shingo Hatakeyama, Rika Nakamura, Rie Fukuhara, Daisuke Noro, Toshikazu Tanaka, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yoshihito Yokoyama, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   25 ( 9 )   817 - 824   2018.7

高リスク前立腺癌に対する術前内分泌化学療法+手術療法の治療成績 全生存率の改善に寄与するか?

古家 琢也, 藤田 尚樹, 堀口 裕貴, 小玉 寛健, 野呂 大輔, 成田 拓磨, 萩原 和久, 及川 真亮, 今西 健吾, 米山 徹, 今井 篤, 橋本 安弘, 大山 力

泌尿器外科   31 ( 臨増 )   825 - 825   2018.6

癌性糖鎖変異PSA-Giと既存PSA検査による前立腺癌の診断能の比較

米山 徹, 飛澤 悠葵, 金子 智典, 彼谷 高敏, 畠山 真吾, 今井 篤, 米山 高弘, 橋本 安弘, 古家 琢也, 須田 美彦, 大山 力

泌尿器外科   31 ( 臨増 )   809 - 809   2018.6

造影濃度の減少は進行性腎細胞癌患者において術前分子標的療法に対する腫瘍反応を予測する

細越 正吾, 畠山 真吾, 平井 秀明, 諸橋 聡子, 鬼島 宏, 山本 隼人, 飛澤 悠葵, 米山 徹, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   31 ( 臨増 )   806 - 806   2018.6

Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.

Koichi Kido, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

European urology focus   2018.5

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Masaki Momota, Shingo Hatakeyama, Hayato Yamamoto, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   9 ( 33 )   23047 - 23057   2018.5

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Masaki Momota, Shingo Hatakeyama, Hayato Yamamoto, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   9 ( 33 )   23047 - 23057   2018.5

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.

Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

Oncotarget   9 ( 25 )   17396 - 17405   2018.4

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.

Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

Oncotarget   9 ( 25 )   17396 - 17405   2018.4

Partial Cystectomy of Paraganglioma of the Urinary Bladder Before Living Kidney Transplantation: Case Report

K. Kido, S. Hatakeyama, I. Hamano, H. Yamamoto, A. Imai, T. Yoneyama, Y. Hashimoto, T. Koie, T. Fujita, R. Murakami, H. Tomita, T. Suzuki, S. Narumi, C. Ohyama

Transplantation Proceedings   50 ( 3 )   898 - 901   2018.4

Partial Cystectomy of Paraganglioma of the Urinary Bladder Before Living Kidney Transplantation: Case Report.

K Kido, S Hatakeyama, I Hamano, H Yamamoto, A Imai, T Yoneyama, Y Hashimoto, T Koie, T Fujita, R Murakami, H Tomita, T Suzuki, S Narumi, C Ohyama

Transplantation proceedings   50 ( 3 )   898 - 901   2018.4

進行性上部尿路上皮癌における化学療法前の予後予測因子としての血清コリンエステラーゼ値の有用性の検討

米山 高弘, 及川 真亮, 萩原 和久, 野呂 大輔, 今西 賢悟, 米山 徹, 山本 勇人, 盛 和行, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   106回   OP - 591   2018.4

T4/M1前立腺癌に対するネオアジュバント療法+ロボット支援前立腺全摘除術の有用性

古家 琢也, 大山 力, 橋本 安弘, 米山 高弘, 畠山 真吾, 今井 篤, 山本 勇人, 米山 徹, 日下 歩, 細越 正吾, 小玉 寛健, 得居 範子

日本泌尿器科学会総会   106回   OP - 624   2018.4

医療コストを改善する腎尿管全摘除術医療コストを改善する腎尿管全摘術後の至適術後フォローアップ・プロトコルの検討

百田 匡毅, 畠山 真吾, 山本 勇人, 飛澤 悠葵, 米山 徹, 米山 高弘, 橋本 安弘, 古家 琢也, 岩渕 郁也, 小笠原 賢, 川口 利明, 大山 力

日本泌尿器科学会総会   106回   PP1 - 058   2018.4

筋層浸潤膀胱癌に対する術前化学療法の施行割合と治療効果

阿南 剛, 畠山 真吾, 藤田 尚紀, 岩村 大径, 米山 高弘, 橋本 安弘, 古家 琢也, 伊藤 弘之, 吉川 和暁, 川口 俊明, 佐藤 信, 大山 力

日本泌尿器科学会総会   106回   PP2 - 042   2018.4

精巣腫瘍患者の精子凍結保存および妊孕性についての検討

野呂 大輔, 畠山 真吾, 濱野 逸人, 小玉 寛健, 日下 歩, 米山 徹, 今井 篤, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   106回   PP3 - 101   2018.4

Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma.

Masaaki Oikawa, Shingo Hatakeyama, Tohru Yoneyma, Yuki Tobisawa, Takuma Narita, Hayato Yamamoto, Yasuhiro Hashimoto, Takuya Koie, Shintaro Narita, Atsushi Sasaki, Norihiko Tsuchiya, Tomonori Habuchi, Ippei Takahashi, Shigeyuki Nakaji, Chikara Ohyama

European urology focus   4 ( 3 )   405 - 411   2018.4

BCG生菌耐性膀胱癌細胞株に対するナノパーティクルBCGの直接効果と耐性株の遺伝子発現解析

盛 和行, 米山 徹, 小玉 寛健, 日下 歩, 細越 正吾, 得居 範子, 山本 勇人, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   106回   OP - 586   2018.4

KK47細胞BCG生菌耐性株に対するナノパーティクルBCGの直接効果と耐性株の遺伝子発現解析

盛 和行, 米山 徹, 小玉 寛健, 日下 歩, 細越 正吾, 得居 範子, 山本 勇人, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   31 ( 4 )   401 - 402   2018.4

mHSPCに対する早期ドセタキセル療法の初期成績

米山 高弘, 及川 真亮, 萩原 和久, 野呂 大輔, 今西 賢悟, 米山 徹, 山本 勇人, 盛 和行, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   106回   OP - 654   2018.4

The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.

Masaki Momota, Shingo Hatakeyama, Noriko Tokui, Tendo Sato, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Satoshi Narita, Toshiaki Kawaguchi, Chikara Ohyama

European urology focus   2018.3

表面プラズモン共鳴励起増強蛍光分光(SPFS)を用いた高感LacdiNAc-PSA測定法の開発

金子 智典, 彼谷 高敏, 米山 徹, 飛澤 悠葵, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力, 須田 美彦

日本分子腫瘍マーカー研究会誌   33   19 - 20   2018.3

Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.

Hirotaka Horiguchi, Takahiro Yoneyama, Shingo Hatakeyama, Noriko Tokui, Tendo Sato, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuaki Yoshikawa, Satoshi Narita, Toshiaki Kawaguchi, Chikara Ohyama

Medical oncology (Northwood, London, England)   35 ( 4 )   41 - 41   2018.2

Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.

Hirotaka Horiguchi, Takahiro Yoneyama, Shingo Hatakeyama, Noriko Tokui, Tendo Sato, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuaki Yoshikawa, Satoshi Narita, Toshiaki Kawaguchi, Chikara Ohyama

Medical oncology (Northwood, London, England)   35 ( 4 )   41 - 41   2018.2

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Koichi Kido, Shingo Hatakeyama, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama

International journal of clinical oncology   2018.2

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.

Hirotaka Horiguchi, Shingo Hatakeyama, Go Anan, Yuka Kubota, Hirotake Kodama, Masaki Momota, Koichi Kido, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   9 ( 9 )   8746 - 8755   2018.2

Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.

Daisuke Noro, Takuya Koie, Yasuhiro Hashimoto, Toshikazu Tanaka, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Shingo Hatakeyama, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota

Japanese journal of clinical oncology   48 ( 2 )   184 - 189   2018.2

Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava.

Yoshimi Tanaka, Shingo Hatakeyama, Shogo Hosogoe, Toshikazu Tanaka, Itsuto Hamano, Ayumu Kusaka, Hiromich Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   23 ( 1 )   134 - 141   2018.2

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.

Hirotaka Horiguchi, Shingo Hatakeyama, Go Anan, Yuka Kubota, Hirotake Kodama, Masaki Momota, Koichi Kido, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   9 ( 9 )   8746 - 8755   2018.1

Slow Progression of Aortic Calcification Is a Potential Benefit of Pre-emptive Kidney Transplantation

H. Mursawa, S. Hatakeyama, H. Yamamoto, Y. Tanaka, O. Soma, T. Matsumoto, T. Yoneyama, Y. Hashimoto, T. Koie, T. Fujita, R. Murakami, H. Saitoh, T. Suzuki, S. Narumi, C. Ohyama

Transplantation Proceedings   50 ( 1 )   145 - 149   2018.1

Slow Progression of Aortic Calcification Is a Potential Benefit of Pre-emptive Kidney Transplantation.

H Mursawa, S Hatakeyama, H Yamamoto, Y Tanaka, O Soma, T Matsumoto, T Yoneyama, Y Hashimoto, T Koie, T Fujita, R Murakami, H Saitoh, T Suzuki, S Narumi, C Ohyama

Transplantation proceedings   50 ( 1 )   145 - 149   2018.1

Onco-testicular sperm extraction (Onco-TESE) from a single testis with metachronous bilateral testicular cancer: a case report.

Itsuto Hamano, Shingo Hatakeyama, Rika Nakamura, Rie Fukuhara, Daisuke Noro, Hiroko Seino, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yoshihito Yokoyama, Chikara Ohyama

Basic and clinical andrology   28   1 - 1   2018

Development of high sensitive LacdiNAc-PSA immunoassay system with surface plasmon field- enhanced fluorescence spectroscopy (SPFS)

Kaneko Tomonori, Kaya Takatoshi, Yoneyama Tohru, Tobisawa Yuki, Hatakeyama Shingo, Hashimoto Yasuhiro, Koie Takuya, Ohyama Chikara, Suda Yoshihiko

Japan Journal of Molecular Tumor Marker Research   33 ( 0 )   19 - 20   2018

Onco-testicular sperm extraction (Onco-TESE) from a single testis with metachronous bilateral testicular cancer: a case report.

Itsuto Hamano, Shingo Hatakeyama, Rika Nakamura, Rie Fukuhara, Daisuke Noro, Hiroko Seino, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yoshihito Yokoyama, Chikara Ohyama

Basic and clinical andrology   28   1 - 1   2018

A Case of Fibrous Pseudotumor in the Scrotum: Challenge for Diagnosis and Testicular Preservation.

Hirotake Kodama, Shingo Hatakeyama, Teppei Matsumoto, Toshikazu Tanaka, Hirotaka Horiguchi, Yuka Kubota, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Case reports in urology   2018   1 - 4   2018

Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.

Toshikazu Tanaka, Tohru Yoneyama, Daisuke Noro, Kengo Imanishi, Yuta Kojima, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Shizuka Kurauchi, Ippei Takahashi, Chikara Ohyama

International journal of molecular sciences   18 ( 12 )   2017.12

Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.

Toshikazu Tanaka, Tohru Yoneyama, Daisuke Noro, Kengo Imanishi, Yuta Kojima, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Shizuka Kurauchi, Ippei Takahashi, Chikara Ohyama

International journal of molecular sciences   18 ( 12 )   2017.12

Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy.

Katsumi Hirose, Masahiko Aoki, Mariko Sato, Hiroyoshi Akimoto, Yasuhiro Hashimoto, Atsushi Imai, Noritaka Kamimura, Hideo Kawaguchi, Yoshiomi Hatayama, Ichitaro Fujioka, Mitsuki Tanaka, Chikara Ohyama, Yoshihiro Takai

Radiation oncology (London, England)   12 ( 1 )   192 - 192   2017.12

Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy.

Katsumi Hirose, Masahiko Aoki, Mariko Sato, Hiroyoshi Akimoto, Yasuhiro Hashimoto, Atsushi Imai, Noritaka Kamimura, Hideo Kawaguchi, Yoshiomi Hatayama, Ichitaro Fujioka, Mitsuki Tanaka, Chikara Ohyama, Yoshihiro Takai

Radiation oncology (London, England)   12 ( 1 )   192 - 192   2017.12

Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.

Naoki Fujita, Takuya Koie, Chikara Ohyama, Yoshimi Tanaka, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Yasuhiro Hashimoto

International journal of clinical oncology   22 ( 6 )   1087 - 1093   2017.12

Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.

Naoki Fujita, Takuya Koie, Chikara Ohyama, Yoshimi Tanaka, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Yasuhiro Hashimoto

International journal of clinical oncology   22 ( 6 )   1087 - 1093   2017.12

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.

Yuka Kubota, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hiromichi Iwamura, Jotaro Mikami, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 60 )   101500 - 101508   2017.11

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.

Yuka Kubota, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hiromichi Iwamura, Jotaro Mikami, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 60 )   101500 - 101508   2017.11

Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.

Daisuke Noro, Takuya Koie, Yasuhiro Hashimoto, Toshikazu Tanaka, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Shingo Hatakeyama, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota

Japanese journal of clinical oncology   48 ( 2 )   184 - 189   2017.11

Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.

Toshikazu Tanaka, Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Atsushi Imai, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Tohru Yoneyama, Hirotaka Horiguchi, Hirotake Kodama, Takahiro Yoneyama

Japanese journal of clinical oncology   47 ( 11 )   1078 - 1082   2017.11

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.

Go Anan, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Toshikazu Tanaka, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   8 ( 49 )   86130 - 86142   2017.10

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.

Go Anan, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Toshikazu Tanaka, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   8 ( 49 )   86130 - 86142   2017.10

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Hirotake Kodama, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Go Anan, Ken Fukushi, Takuma Narita, Toshikazu Tanaka, Yuka Kubota, Hirotaka Horiguchi, Masaki Momota, Koichi Kido, Teppei Matsumoto, Osamu Soma, Itsuto Hamano, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   8 ( 47 )   83183 - 83194   2017.10

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.

Itsuto Hamano, Shingo Hatakeyama, Hiromichi Iwamurau, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Ayumu Kusaka, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 37 )   61404 - 61414   2017.9

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.

Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 39 )   65492 - 65505   2017.9

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.

Takuma Narita, Shingo Hatakeyama, Takuya Koie, Shogo Hosogoe, Teppei Matsumoto, Osamu Soma, Hayato Yamamoto, Tohru Yoneyama, Yuki Tobisawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BMC urology   17 ( 1 )   72 - 72   2017.8

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.

Takuma Narita, Shingo Hatakeyama, Takuya Koie, Shogo Hosogoe, Teppei Matsumoto, Osamu Soma, Hayato Yamamoto, Tohru Yoneyama, Yuki Tobisawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BMC urology   17 ( 1 )   72 - 72   2017.8

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Hirotake Kodama, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Go Anan, Ken Fukushi, Takuma Narita, Toshikazu Tanaka, Yuka Kubota, Hirotaka Horiguchi, Masaki Momota, Koichi Kido, Teppei Matsumoto, Osamu Soma, Itsuto Hamano, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   8 ( 47 )   83183 - 83194   2017.8

Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.

Toshikazu Tanaka, Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Atsushi Imai, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Tohru Yoneyama, Hirotaka Horiguchi, Hirotake Kodama, Takahiro Yoneyama

Japanese journal of clinical oncology   47 ( 11 )   1078 - 1082   2017.8

Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.

Daisuke Noro, Tohru Yoneyama, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Hideo Sasaki, Mitsuru Saito, Hiroshi Harada, Tatsuya Chikaraishi, Hideki Ishida, Kazunari Tanabe, Shigeru Satoh, Chikara Ohyama

International journal of molecular sciences   18 ( 8 )   2017.8

Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.

Daisuke Noro, Tohru Yoneyama, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Hideo Sasaki, Mitsuru Saito, Hiroshi Harada, Tatsuya Chikaraishi, Hideki Ishida, Kazunari Tanabe, Shigeru Satoh, Chikara Ohyama

International journal of molecular sciences   18 ( 8 )   2017.8

マイクロキャピラリー電気泳動免疫蛍光測定装置を用いた新規の前立腺癌関連糖鎖変異マーカーS2、3PSA測定に基づく診断手方

石川 友一, 米山 徹, 飛澤 悠葵, 畠山 真吾, 黒澤 竜雄, 橋本 安弘, 古家 琢也, 中村 賢治, 大山 力

泌尿器外科   30 ( 8 )   1301 - 1303   2017.8

表面プラズモン共鳴励起増強蛍光分光(SPFS)を用いた高感LacdiNAc-PSA測定法の開発

金子 智典, 彼谷 高敏, 米山 徹, 飛澤 悠葵, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力, 須田 美彦

日本分子腫瘍マーカー研究会プログラム・講演抄録   37回   38 - 39   2017.8

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.

Yoshimi Tanaka, Shingo Hatakeyama, Toshikazu Tanaka, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

PloS one   12 ( 7 )   e0182136 - e0182136   2017.7

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Yoshimi Tanaka, Kazuhisa Hagiwara, Hideaki Hirai, Satoko Morohashi, Hiroshi Kijima, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Oncotarget   8 ( 30 )   49749 - 49756   2017.7

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Yoshimi Tanaka, Kazuhisa Hagiwara, Hideaki Hirai, Satoko Morohashi, Hiroshi Kijima, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Oncotarget   8 ( 30 )   49749 - 49756   2017.7

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.

Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 39 )   65492 - 65505   2017.7

Post-chemotherapy PD-L1 expression correlates with clinical outcomes in Japanese bladder cancer patients treated with total cystectomy.

Daisuke Noro, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Toshiaki Kawaguchi, Chikara Ohyama

Medical oncology (Northwood, London, England)   34 ( 6 )   117 - 117   2017.6

Post-chemotherapy PD-L1 expression correlates with clinical outcomes in Japanese bladder cancer patients treated with total cystectomy.

Daisuke Noro, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Toshiaki Kawaguchi, Chikara Ohyama

Medical oncology (Northwood, London, England)   34 ( 6 )   117 - 117   2017.6

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.

Itsuto Hamano, Shingo Hatakeyama, Hiromichi Iwamurau, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Ayumu Kusaka, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 37 )   61404 - 61414   2017.5

Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.

Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Medical oncology (Northwood, London, England)   34 ( 5 )   90 - 90   2017.5

血清N結合型糖鎖の網羅的質量解析による精巣腫瘍の糖鎖性腫瘍マーカーの検索

成田 拓磨, 畠山 真吾, 今井 篤, 山本 勇人, 米山 高弘, 米山 徹, 飛澤 悠葵, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   30 ( 臨増 )   934 - 934   2017.5

前立腺全摘除術後のPSA再発予測因子としてのButyrylcholinesteraseの有用性

萩原 和久, 古家 琢也, 及川 真亮, 田中 壽和, 成田 拓磨, 野呂 大輔, 福士 謙, 米山 徹, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 大山 力

泌尿器外科   30 ( 臨増 )   880 - 880   2017.5

前立腺癌バイオマーカーのパラダイムシフト 糖鎖マーカーを利用した前立腺癌術後の予後予測

米山 徹, 飛澤 悠葵, 金子 智典, 彼谷 高敏, 畠山 真吾, 橋本 安弘, 古家 琢也, 須田 美彦, 大山 力

泌尿器外科   30 ( 臨増 )   671 - 674   2017.5

尿路上皮癌症例における血清N-glycanの網羅的質量解析

及川 真亮, 畠山 真吾, 今井 篤, 米山 高弘, 米山 徹, 飛澤 悠葵, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   30 ( 臨増 )   892 - 892   2017.5

筋層浸潤膀胱癌シスプラチン不適格症例に対するゲムシタビン+カルボプラチンによる術前化学療法

村澤 洋美, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力, 岩渕 郁哉, 小笠原 賢, 川口 俊明, 米山 徹, 盛 和行

泌尿器外科   30 ( 臨増 )   911 - 911   2017.5

Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.

Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Medical oncology (Northwood, London, England)   34 ( 5 )   90 - 90   2017.5

Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.

Kazuhisa Hagiwara, Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Yuki Tobisawa, Tohru Yoneyama

International urology and nephrology   49 ( 5 )   811 - 816   2017.5

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   24 ( 5 )   361 - 366   2017.5

Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

European urology focus   2017.4

Clinical relevance of aortic calcification in urolithiasis patients.

Toshikazu Tanaka, Shingo Hatakeyama, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

BMC urology   17 ( 1 )   25 - 25   2017.4

Clinical relevance of aortic calcification in urolithiasis patients.

Toshikazu Tanaka, Shingo Hatakeyama, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

BMC urology   17 ( 1 )   25 - 25   2017.4

高リスク前立腺癌に対する術前化学ホルモン療法の費用対効果の検討

萩原 和久, 畠山 真吾, 米山 徹, 盛 和行, 今井 篤, 米山 高弘, 橋本 安弘, 古家 琢也, 羽渕 友則, 荒井 陽一, 土谷 順彦, 大山 力

日本泌尿器科学会総会   105回   OP65 - 3   2017.4

ナノパーティクルBCGはBCG生菌double耐性株に対して直接効果を有する

盛 和行, 米山 徹, 野呂 大輔, 成田 拓磨, 田中 壽和, 萩原 和久, 及川 真亮, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   105回   OP63 - 8   2017.4

マイクロキャピラリー電気泳動免疫蛍光検出装置を用いた新規の前立腺癌関連糖鎖変異マーカーS2、3PSA測定に基づく診断手法

石川 友一, 米山 徹, 飛澤 悠葵, 畠山 真吾, 黒澤 竜雄, 橋本 安弘, 古家 琢也, 中村 賢治, 大山 力

日本泌尿器科学会総会   105回   PP17 - 07   2017.4

ロボット支援膀胱全摘除術および完全体腔内回腸新膀胱造設術

古家 琢也, 萩原 和久, 田中 壽和, 野呂 大輔, 及川 真亮, 成田 拓磨, 米山 徹, 盛 和行, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 大山 力

日本泌尿器科学会総会   105回   UP09 - 3   2017.4

尿路上皮癌症例における新規バイオマーカーとしての血清N-glycanの網羅的質量解析

及川 真亮, 畠山 真吾, 成田 拓磨, 今井 篤, 米山 高弘, 米山 徹, 橋本 安弘, 古家 高弘, 大山 力

日本泌尿器科学会総会   105回   OP64 - 1   2017.4

精巣腫瘍患者における精子凍結保存と妊孕性に関する検討

野呂 大輔, 畠山 真吾, 田中 壽和, 成田 拓磨, 米山 徹, 今井 篤, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   105回   PP56 - 08   2017.4

糖鎖マーカーを利用した前立腺癌診断と術後の予後予測

米山 徹, 飛澤 悠葵, 石川 友一, 金子 智典, 彼谷 高敏, 畠山 真吾, 橋本 安弘, 古家 琢也, 須田 美彦, 大山 力

日本泌尿器科学会総会   105回   UP12 - 3   2017.4

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Osamu Soma, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   22 ( 2 )   366 - 372   2017.4

BCG生菌double耐性株に対するナノパーティクスBCGの直接効果

盛 和行, 米山 徹, 野呂 大輔, 成田 拓磨, 田中 壽和, 萩原 和久, 及川 真亮, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   30 ( 4 )   442 - 443   2017.4

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   2017.3

The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Atsushi Yamauchi, Toru Shimazui, Mikinobu Ohtani

Japanese journal of clinical oncology   47 ( 3 )   252 - 256   2017.3

The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Atsushi Yamauchi, Toru Shimazui, Mikinobu Ohtani

Japanese journal of clinical oncology   47 ( 3 )   252 - 256   2017.3

Solitary Fibrous Tumor of the Prostate Which Was Initially Misdiagnosed as Prostate Cancer.

Soma Osamu, Hiromi Murasawa, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Case reports in urology   2017   3594914 - 3594914   2017.2

An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.

Tomokazu Ishikawa, Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Tatsuo Kurosawa, Kenji Nakamura, Shintaro Narita, Koji Mitsuzuka, Wilhelmina Duivenvoorden, Jehonathan H Pinthus, Yasuhiro Hashimoto, Takuya Koie, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama

International journal of molecular sciences   18 ( 2 )   2017.2

An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.

Tomokazu Ishikawa, Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Tatsuo Kurosawa, Kenji Nakamura, Shintaro Narita, Koji Mitsuzuka, Wilhelmina Duivenvoorden, Jehonathan H Pinthus, Yasuhiro Hashimoto, Takuya Koie, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama

International journal of molecular sciences   18 ( 2 )   2017.2

Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.

Kazuhisa Hagiwara, Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Yuki Tobisawa, Tohru Yoneyama

International urology and nephrology   2017.2

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.

Ken Fukushi, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Osamu Soma, Teppei Matsumoto, Itsuto Hamano, Takuma Narita, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

BMC urology   17 ( 1 )   13 - 13   2017.2

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.

Ken Fukushi, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Osamu Soma, Teppei Matsumoto, Itsuto Hamano, Takuma Narita, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

BMC urology   17 ( 1 )   13 - 13   2017.2

The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.

Hiromi Murasawa, Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi

International journal of clinical oncology   22 ( 1 )   159 - 165   2017.2

The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.

Hiromi Murasawa, Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi

International journal of clinical oncology   22 ( 1 )   159 - 165   2017.2

Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.

Kazuhisa Hagiwara, Yuki Tobisawa, Takatoshi Kaya, Tomonori Kaneko, Shingo Hatakeyama, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Yoshihiko Suda, Chikara Ohyama, Tohru Yoneyama

International journal of molecular sciences   18 ( 2 )   2017.1

Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.

Kazuhisa Hagiwara, Yuki Tobisawa, Takatoshi Kaya, Tomonori Kaneko, Shingo Hatakeyama, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Yoshihiko Suda, Chikara Ohyama, Tohru Yoneyama

International journal of molecular sciences   18 ( 2 )   2017.1

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.

Yoshimi Tanaka, Shingo Hatakeyama, Toshikazu Tanaka, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

PloS one   12 ( 7 )   e0182136   2017

Solitary Fibrous Tumor of the Prostate Which Was Initially Misdiagnosed as Prostate Cancer.

Soma Osamu, Hiromi Murasawa, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Case reports in urology   2017   3594914 - 3594914   2017

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Osamu Soma, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   2016.12

膀胱癌・前立腺癌合併症例に対してロボット支援膀胱全摘除術+体腔内回腸新膀胱造設術を施行した一例

田中 壽和, 城戸 宏一, 百田 匡毅, 野呂 大輔, 及川 匡亮, 萩原 和久, 成田 拓磨, 米山 徹, 今井 篤, 畠山 真吾, 米山 高広, 橋本 安弘, 吉家 琢也, 大山 力

泌尿器外科   29 ( 12 )   1793 - 1793   2016.12

Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma.

Masaaki Oikawa, Shingo Hatakeyama, Tohru Yoneyma, Yuki Tobisawa, Takuma Narita, Hayato Yamamoto, Yasuhiro Hashimoto, Takuya Koie, Shintaro Narita, Atsushi Sasaki, Norihiko Tsuchiya, Tomonori Habuchi, Ippei Takahashi, Shigeyuki Nakaji, Chikara Ohyama

European urology focus   2016.11

The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy.

Katsumi Hirose, Masahiko Aoki, Mariko Sato, Hiroyoshi Akimoto, Yasuhiro Hashimoto, Atsushi Imai, Noritaka Kamimura, Hideo Kawaguchi, Yoshiomi Hatayama, Ichitaro Fujioka, Mitsuki Tanaka, Chikara Ohyama, Yoshihiro Takai

Japanese journal of radiology   34 ( 11 )   718 - 723   2016.11

The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy.

Hirose K, Aoki M, Sato M, Akimoto H, Hashimoto Y, Imai A, Kamimura N, Kawaguchi H, Hatayama Y, Fujioka I, Tanaka M, Ohyama C, Takai Y

Japanese journal of radiology   34 ( 11 )   718 - 723   2016.11

The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy.

Katsumi Hirose, Masahiko Aoki, Mariko Sato, Hiroyoshi Akimoto, Yasuhiro Hashimoto, Atsushi Imai, Noritaka Kamimura, Hideo Kawaguchi, Yoshiomi Hatayama, Ichitaro Fujioka, Mitsuki Tanaka, Chikara Ohyama, Yoshihiro Takai

Japanese journal of radiology   34 ( 11 )   718 - 723   2016.11

高齢者に対するBCG上部尿路灌流療法の治療成績

米山 高弘, 野呂 大輔, 福士 謙, 米山 徹, 盛 和行, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本老年泌尿器科学会誌   29   54 - 54   2016.10

ハイリスク前立腺癌に対するneoadjuvant療法 LHRHアゴニストとアンタゴニストの比較

古家 琢也, 野呂 大輔, 田中 壽和, 萩原 和久, 成田 琢磨, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 大山 力, 米山 徹, 盛 和行

日本癌治療学会学術集会抄録集   54回   P60 - 1   2016.10

尿路 尿路上皮がんの集学的治療 進行性上部尿路上皮癌に対するCarboplatinをベースとした化学療法の治療成績

米山 高弘, 及川 真亮, 成田 拓麿, 野呂 大輔, 萩原 和久, 田中 壽一, 福士 謙, 米山 徹, 盛 和行, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本癌治療学会学術集会抄録集   54回   WS66 - 1   2016.10

確定診断が困難であった前立腺孤発性線維性腫瘍の1例

相馬 理, 萩原 和久, 福士 謙, 成田 拓磨, 米山 徹, 盛 和行, 畠山 真吾, 橋本 安弘, 大山 力

泌尿器外科   29 ( 9 )   1499 - 1499   2016.9

アキシチニブによる術前治療により病理学的CRを得たcT3b腎細胞癌の1例

杉山 尚樹, 飛澤 悠葵, 米山 徹, 盛 和行, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   29 ( 9 )   1494 - 1494   2016.9

副腎に発生した血管筋脂肪腫の一例

相馬 理, 松本 哲平, 杉山 尚樹, 米山 徹, 飛澤 悠葵, 盛 和行, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   29 ( 9 )   1493 - 1493   2016.9

Management of High-Risk Prostate Cancer and Left Ectopic Ureter Inserting into Seminal Vesicle with Ipsilateral Hypoplastic Kidney of a Young Patient : A Case Report

Matsumoto Teppei, Koie Takuya, Soma Osamu, Kusaka Ayumu, Hosogoe Shogo, Hamano Itsuto, Imai Atsushi, Hatakeyama Shingo, Yoneyama Takahiro, Hashimoto Yasuhiro, Ohyama Chikara

Hinyokika Kiyo   62 ( 6 )   329 - 333   2016.6

[Management of High-Risk Prostate Cancer and Left Ectopic Ureter Inserting into Seminal Vesicle with Ipsilateral Hypoplastic Kidney of a Young Patient : A Case Report].

Matsumoto T, Koie T, Soma O, Kusaka A, Hosogoe S, Hamano I, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   62 ( 6 )   329 - 33   2016.6

[Management of High-Risk Prostate Cancer and Left Ectopic Ureter Inserting into Seminal Vesicle with Ipsilateral Hypoplastic Kidney of a Young Patient : A Case Report].

Teppei Matsumoto, Takuya Koie, Osamu Soma, Ayumu Kusaka, Shogo Hosogoe, Itsuto Hamano, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica   62 ( 6 )   329 - 33   2016.6

[Postoperative complications and management after radical prostatectomy].

Koie T, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C

Nihon rinsho. Japanese journal of clinical medicine   74 Suppl 3   456 - 60   2016.5

ロボット支援U字回腸新膀胱造設術の短期成績

米山 高弘, 小島 由太, 杉山 尚樹, 飛澤 悠葵, 米山 徹, 今井 篤, 盛 和行, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   29 ( 臨増 )   905 - 905   2016.5

pTを術前に予測する新規前立腺癌悪性度診断マーカーの開発

飛澤 悠葵, 米山 徹, 小島 由太, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   29 ( 臨増 )   931 - 931   2016.5

Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism.

Naoki Fujita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Takeshi Nigawara, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   23 ( 5 )   412 - 7   2016.5

Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study.

Kazuhisa Hagiwara, Takuya Koie, Hiromichi Iwamura, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BioMed research international   2016   4975851 - 4975851   2016.4

Safety and Effectiveness of Marginal Donor in Living Kidney Transplantation

M. Oikawa, S. Hatakeyama, T. Narita, H. Yamamoto, S. Hosogoe, A. Imai, T. Yoneyama, Y. Hashimoto, T. Koie, T. Fujita, R. Murakami, H. Saitoh, T. Funyu, S. Narumi, C. Ohyama

Transplantation Proceedings   48 ( 3 )   701 - 705   2016.4

Safety and Effectiveness of Marginal Donor in Living Kidney Transplantation.

M Oikawa, S Hatakeyama, T Narita, H Yamamoto, S Hosogoe, A Imai, T Yoneyama, Y Hashimoto, T Koie, T Fujita, R Murakami, H Saitoh, T Funyu, S Narumi, C Ohyama

Transplantation proceedings   48 ( 3 )   701 - 705   2016.4

ロボット支援膀胱全摘除術+U字回腸新膀胱造設術とミニマム創膀胱全摘除術+U字回腸新膀胱造設術の手術成績の検討

米山 高弘, 佐藤 天童, 三上 穣太郎, 小島 由太, 藤田 尚紀, 岩村 大径, 飛澤 悠葵, 米山 徹, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   104回   PP2 - 239   2016.4

前立腺マッサージ尿中Core2 β-1,6-N-acetylglucosaminyltransferaseの検出は前立腺癌の被膜外浸潤予測に有効である

小島 由太, 米山 徹, 畠山 真吾, 盛 和行, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力, 飛澤 悠葵

日本泌尿器科学会総会   104回   PP1 - 109   2016.4

前立腺全摘除術後のPSA再発予測因子としてのButyrylcholinesteraseの有用性

萩原 和久, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力, 飛澤 悠葵, 米山 徹, 盛 和行

日本泌尿器科学会総会   104回   PP1 - 113   2016.4

泌尿器科手術後せん妄のリスク因子の検討

佐藤 天童, 畠山 真吾, 岡本 哲平, 細越 正吾, 山本 勇人, 飛澤 悠葵, 米山 徹, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   104回   PP2 - 327   2016.4

筋層非浸潤膀胱癌に対する単回TURおよび膀胱内注入療法の有用性

相馬 理, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力, 飛澤 悠葵, 米山 徹, 盛 和行

日本泌尿器科学会総会   104回   OP - 217   2016.4

腹部大動脈石灰化は原発性アルドステロン症における腹腔鏡下副腎摘除術抵抗性高血圧のリスク因子である

藤田 尚紀, 畠山 真吾, 山本 勇人, 今井 篤, 飛澤 悠葵, 米山 徹, 米山 高弘, 橋本 安弘, 古家 琢也, 二川原 健, 大山 力

日本泌尿器科学会総会   104回   PP2 - 170   2016.4

血清糖鎖の網羅的解析(グライコミクス)による精巣腫瘍診断マーカーの検索

畠山 真吾, 今井 篤, 山本 勇人, 米山 高弘, 米山 徹, 飛澤 悠葵, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   104回   PP2 - 119   2016.4

表面プラズモン励起増強蛍光分光(SPFS)免疫測定システムによる新規前立腺癌診断マーカーLacdiNAc-PSAの精度評価

米山 徹, 飛澤 悠葵, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   104回   PP1 - 107   2016.4

進行性上部尿路上皮癌に対するCarboplatinをベースとした化学療法の検討

田中 芳美, 福士 謙, 三上 穣太郎, 佐藤 天童, 小島 由太, 岩村 大径, 藤田 尚紀, 米山 徹, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   104回   PP3 - 199   2016.4

Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.

Takuya Koie, Chikara Ohyama, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Shogo Hosogoe, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota

International journal of clinical oncology   21 ( 2 )   379 - 383   2016.4

Cisplatin-unfit進行性膀胱癌に対するCarboplatinをベースとした化学療法の治療成績

米山 高弘, 佐藤 天童, 小島 由太, 三上 穣太郎, 藤田 尚紀, 岩村 大径, 米山 徹, 盛 和行, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   104回   PP1 - 063   2016.4

BCG菌株交替療法についての基礎的検討と耐性化メカニズムの解析

盛 和行, 飛澤 悠葵, 米山 徹, 岩村 大径, 佐藤 天童, 藤田 尚紀, 三上 穣太郎, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   104回   PP1 - 040   2016.4

BCG菌株交替療法についての基礎的検討

盛 和行, 飛澤 悠葵, 米山 徹, 岩村 大径, 佐藤 天童, 藤田 尚紀, 三上 穣太郎, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   29 ( 4 )   383 - 384   2016.4

miRNAによって制御されるlaminin binding O-glycanの前立腺癌神経周囲浸潤、転移における役割

米山 徹, 飛澤 悠葵, 藤田 尚紀, 岩村 大径, 岡本 亜希子, 山本 勇人, 盛 和行, 畠山 真吾, 橋本 安弘, 古家 琢也, 福田 穣, 大山 力

日本泌尿器科学会総会   104回   PP2 - 102   2016.4

Rising star report 腎癌糖鎖マーカーの開発

畠山 真吾, 米山 徹, 飛澤 悠葵, 盛 和行, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   104回   SPS11 - 2   2016.4

I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling.

Jotaro Mikami, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda

Cancer science   107 ( 3 )   359 - 368   2016.2

Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism.

Naoki Fujita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Takeshi Nigawara, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   2016.2

高リスク前立腺癌の全摘後去勢抵抗性・外照射抵抗性局所再発に対して密封小線源療法(BT)を施行した1例

杉山 尚樹, 野呂 大輔, 田中 壽和, 田中 芳美, 萩原 和久, 及川 真亮, 成田 拓磨, 飛澤 悠葵, 米山 徹, 盛 和行, 今井 篤, 橋本 安弘, 大山 力, 高橋 淳, 高橋 伸也

泌尿器外科   29 ( 2 )   186 - 186   2016.2

無阻血腎部分切除を行った長径15cmの腎血管脂肪腫の1例

小島 由太, 飛澤 悠葵, 米山 徹, 盛 和行, 米山 高弘, 藤田 尚紀, 佐藤 天童, 三上 穣太郎, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   29 ( 2 )   199 - 199   2016.2

Core 2 β-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness.

Tendo Sato, Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Yuta Kojima, Jotaro Mikami, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Biochemical and biophysical research communications   470 ( 1 )   150 - 156   2016.1

Core 2 β-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness.

Tendo Sato, Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Yuta Kojima, Jotaro Mikami, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Biochemical and biophysical research communications   470 ( 1 )   150 - 156   2016.1

Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer.

Shingo Hatakeyama, Takuya Koie, Takuma Narita, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

PloS one   11 ( 2 )   e0149544 - e0149544   2016

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents.

Itsuto Hamano, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

SpringerPlus   5 ( 1 )   1917 - 1917   2016

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery.

Tendo Sato, Shingo Hatakeyama, Teppei Okamoto, Hayato Yamamoto, Shogo Hosogoe, Yuki Tobisawa, Tohru Yoneyama, Eiji Hashiba, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuyoshi Hirota, Chikara Ohyama

PloS one   11 ( 5 )   e0153961   2016

Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].

Shingo Hatakeyama, Takuya Koie, Takuma Narita, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

PloS one   11 ( 2 )   e0149544   2016

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents.

Itsuto Hamano, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

SpringerPlus   5 ( 1 )   1917 - 1917   2016

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents.

Hamano I, Hatakeyama S, Yoneyama T, Tobisawa Y, Soma O, Matsumoto T, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

SpringerPlus   5 ( 1 )   1917   2016

Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study.

Kazuhisa Hagiwara, Takuya Koie, Hiromichi Iwamura, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BioMed research international   2016   4975851 - 4975851   2016

I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling.

Jotaro Mikami, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda

Cancer science   2015.12

Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.

Hiromichi Iwamura, Takuya Koie, Osamu Soma, Teppei Matsumoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BMC urology   15   120 - 120   2015.12

高齢者の進行性膀胱癌に対するCarboplatinをベースとした化学療法の治療成績

米山 高弘, 飛澤 悠葵, 米山 徹, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本老年泌尿器科学会誌   28   46 - 46   2015.12

Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer.

Takahiro Yoneyama, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   20 ( 6 )   1179 - 84   2015.12

Intracorporeal urinary diversion

69 ( 11 )   924 - 928   2015.10

Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Shogo Hosogoe, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori

International urology and nephrology   47 ( 9 )   1509 - 1514   2015.9

コンノート株BCG生菌耐性細胞株に対する日本株BCG生菌の効果 交替療法への示唆

盛 和行, 飛澤 悠葵, 米山 徹, 相馬 理, 松本 哲平, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

日本癌治療学会誌   50 ( 3 )   1934 - 1934   2015.9

Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Shogo Hosogoe, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori

International urology and nephrology   47 ( 9 )   1509 - 14   2015.9

鷹揚郷弘前病院で行われた長期生着例を含む腎移植20例のLABScreen検査

盛 和行, 樺澤 憲治, 米山 美穂子, 米山 徹, 飛澤 悠葵, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 村上 礼一, 齋藤 久夫, 山谷 金光, 舟生 富寿, 大山 力

MHC: Major Histocompatibility Complex   22 ( 2Suppl. )   113 - 113   2015.8

ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘除術の治療成績

米山 高弘, 小島 由太, 佐藤 天童, 岩村 大径, 藤田 尚紀, 三上 穣太郎, 杉山 尚樹, 飛澤 悠葵, 米山 徹, 今井 篤, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   28 ( 8 )   1359 - 1361   2015.8

Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.

Takuya Koie, Chikara Ohyama, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Shogo Hosogoe, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota

International journal of clinical oncology   2015.7

Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer.

Takahiro Yoneyama, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   2015.5

前立腺マッサージ尿中のcore2 beta-1,6-N-acetylglucosaminyltransferaseの発現はpT3予測に有用である

飛澤 悠葵, 米山 徹, 畠山 真吾, 岡本 哲平, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   28 ( 臨増 )   822 - 822   2015.5

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.

Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori

BMC urology   15   32 - 32   2015.4

前立腺癌悪性度診断を目的とした前立腺全摘標本におけるGlucosaminyl (N-acetyl) transferase 2(GCNT2)の免疫組織化学的評価はPSA再発予知法として有用である

三上 穣太郎, 小島 由太, 佐藤 天童, 飛澤 悠葵, 米山 徹, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   103回   708 - 708   2015.4

アキシチニブによるプレサージカル療法を施行した腎癌症例の検討

岩村 大径, 三上 穣太郎, 藤田 尚樹, 佐藤 天童, 小島 由太, 飛澤 悠葵, 米山 徹, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   103回   557 - 557   2015.4

ハイリスク前立腺癌に対するネオアジュバント内分泌化学療法後のロボット支援前立腺全摘除術の治療成績

米山 高弘, 得居 範子, 岡本 哲平, 今西 賢悟, 飛澤 悠葵, 米山 徹, 山本 勇人, 今井 篤, 盛 和行, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   103回   551 - 551   2015.4

上部尿路上皮内癌に対するBCG上部尿路灌流療法の長期成績

米山 高弘, 岡本 哲平, 得居 範子, 今西 賢悟, 飛澤 悠葵, 米山 徹, 山本 勇人, 今井 篤, 盛 和行, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   103回   624 - 624   2015.4

前立腺生検検体とマッサージ尿検体におけるC2GnT発現と悪性度の関連

小島 由太, 米山 徹, 畠山 真吾, 岩村 大径, 佐藤 天童, 三上 穣太郎, 藤田 尚紀, 橋本 安弘, 古家 琢也, 大山 力, 飛澤 悠葵

日本泌尿器科学会総会   103回   719 - 719   2015.4

Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.

Takahiro Yoneyama, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   20 ( 2 )   369 - 74   2015.4

日本株BCG耐性細胞株に対するナノパーティクルBCGによる新たな治療薬としての可能性

盛 和行, 飛澤 悠葵, 米山 徹, 細越 正吾, 今西 賢悟, 得居 範子, 岡本 哲平, 山本 勇人, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   28 ( 3 )   315 - 316   2015.3

Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa

Medical oncology (Northwood, London, England)   32 ( 1 )   421 - 421   2015.1

Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa

Medical oncology (Northwood, London, England)   32 ( 1 )   421 - 421   2015.1

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.

Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori

BMC urology   15   32 - 32   2015

A case of primary renal carcinoid tumor.

Toshikazu Tanaka, Hayato Yamamoto, Atsushi Imai, Hatakeyama Shingo, Takahiro Yoneyama, Takuya Koie, Yasuhiro Hashimoto, Chikara Ohyama

Case reports in urology   2015   736213 - 736213   2015

Salvage Brachytherapy for Castration-Resistant and External Beam Radiotherapy-Resistant Local Recurrence 17 Years after Radical Prostatectomy.

Shogo Hosogoe, Osamu Soma, Teppei Matsumoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Masahiko Aoki

Case reports in urology   2015   839738 - 839738   2015

Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.

Yuta Kojima, Tohru Yoneyama, Shingo Hatakeyama, Jotaro Mikami, Tendo Sato, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda, Yuki Tobisawa

PloS one   10 ( 9 )   e0138520 - e0138520   2015

Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.

Hiromichi Iwamura, Takuya Koie, Osamu Soma, Teppei Matsumoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BMC urology   15   120 - 120   2015

筋層浸潤膀胱癌に対する術前化学療法および体腔内操作によるロボット支援膀胱全摘除術と回腸新膀胱造設術

古家 琢也, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 大山 力

Japanese Journal of Endourology   28 ( 1 )   73 - 78   2015

Salvage Brachytherapy for Castration-Resistant and External Beam Radiotherapy-Resistant Local Recurrence 17 Years after Radical Prostatectomy.

Shogo Hosogoe, Osamu Soma, Teppei Matsumoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Masahiko Aoki

Case reports in urology   2015   839738 - 839738   2015

A case of primary renal carcinoid tumor.

Toshikazu Tanaka, Hayato Yamamoto, Atsushi Imai, Hatakeyama Shingo, Takahiro Yoneyama, Takuya Koie, Yasuhiro Hashimoto, Chikara Ohyama

Case reports in urology   2015   736213 - 736213   2015

Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.

Yuta Kojima, Tohru Yoneyama, Shingo Hatakeyama, Jotaro Mikami, Tendo Sato, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda, Yuki Tobisawa

PloS one   10 ( 9 )   e0138520   2015

Leiomyosarcoma of the Prostate Treated with Neoadjuvant Intra-Arterial Chemotherapy and Pelvic Excenteration ; A Case Report

Noro Daisuke, Yoneyama Takahiro, Hagiwara Kazuhisa, Mori Kazuyuki, Yamamoto Hayato, Hashimoto Yasuhiro, Koie Takuya, Ohyama Chikara

Hinyokika Kiyo   60 ( 11 )   579 - 582   2014.11

[Leiomyosarcoma of the prostate treated with neoadjuvant intra-arterial chemotherapy and pelvic excenteration ; a case report].

Noro D, Yoneyama T, Hagiwara K, Mori K, Yamamoto H, Hashimoto Y, Koie T, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   60 ( 11 )   579 - 82   2014.11

[Leiomyosarcoma of the prostate treated with neoadjuvant intra-arterial chemotherapy and pelvic excenteration ; a case report].

Daisuke Noro, Takahiro Yoneyama, Kazuhisa Hagiwara, Kazuyuki Mori, Hayato Yamamoto, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica   60 ( 11 )   579 - 82   2014.11

Testicular metastasis of prostate cancer: a case report.

Ayumu Kusaka, Takuya Koie, Hayato Yamamoto, Itsuto Hamano, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama

Case reports in oncology   7 ( 3 )   643 - 647   2014.9

Testicular metastasis of prostate cancer: a case report.

Ayumu Kusaka, Takuya Koie, Hayato Yamamoto, Itsuto Hamano, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama

Case reports in oncology   7 ( 3 )   643 - 7   2014.9

Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Masato Kitayam, Kazuyoshi Hirota

Urologic oncology   32 ( 6 )   820 - 825   2014.8

Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Masato Kitayam, Kazuyoshi Hirota

Urologic oncology   32 ( 6 )   820 - 5   2014.8

日本株BCG耐性膀胱癌細胞株に対するコンノート株及びナノパーティクルBCGの直接効果

盛 和行, 飛澤 悠葵, 米山 徹, 村澤 洋美, 今西 賢悟, 得居 範子, 岡本 哲平, 山本 勇人, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

日本癌治療学会誌   49 ( 3 )   1240 - 1240   2014.6

Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.

Takahiro Yoneyama, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   2014.5

Preoperative butyrylcholinesterase level as an independent predictor of overall survival in clear cell renal cell carcinoma patients treated with nephrectomy.

Takuya Koie, Chikara Ohyama, Jotaro Mikami, Hiromichi Iwamura, Naoki Fujita, Tendo Sato, Yuta Kojima, Ken Fukushi, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Masato Kitayama, Kazuyoshi Hirota

TheScientificWorldJournal   2014   948305 - 948305   2014.5

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa

Medical oncology (Northwood, London, England)   31 ( 5 )   949 - 949   2014.5

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa

Medical oncology (Northwood, London, England)   31 ( 5 )   949 - 949   2014.5

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Masahiko Aoki, Yoshihiro Takai

World journal of surgical oncology   12   134 - 134   2014.4

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Masahiko Aoki, Yoshihiro Takai

World journal of surgical oncology   12   134 - 134   2014.4

増刊号特集 前立腺癌の診療ナビゲーション-わかりやすく丁寧に! II　前立腺癌の診断 6.病理とGleason score

畠山 真吾, 諸橋 聡子, 橋本 安弘

臨床泌尿器科   68 ( 4 )   65 - 69   2014.4

難治性間質性膀胱炎に対し膀胱全摘除術、回腸新膀胱造設術を施行した2例

岡本 哲平, 得居 範子, 杉山 尚樹, 鈴木 裕一朗, 工藤 茂将, 米山 高弘, 橋本 安弘, 古家 琢也, 米山 徹, 盛 和行, 神村 典孝, 大山 力

泌尿器外科   27 ( 4 )   521 - 521   2014.4

コンノート株BCGは日本株BCG耐性膀胱癌細胞株に対して直接効果を有する

盛 和行, 米山 徹, 飛澤 悠葵, 山本 勇人, 岡本 亜希子, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   102回   540 - 540   2014.4

不妊治療中に偶然発見された悪性褐色細胞腫の1例

萩原 和久, 及川 真亮, 杉山 尚樹, 鈴木 裕一郎, 飛澤 悠葵, 米山 徹, 岡本 亜希子, 山本 勇人, 今井 篤, 盛 和行, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   27 ( 4 )   548 - 548   2014.4

外腸骨静脈が完全閉塞していた腎移植レシピエントの1例

鈴木 裕一朗, 萩原 和久, 及川 真亮, 杉山 尚樹, 飛澤 悠葵, 米山 徹, 山本 勇人, 岡本 亜希子, 今井 篤, 盛 和行, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   27 ( 4 )   546 - 546   2014.4

尿管サルコイドーシスの1例

工藤 茂将, 得居 範子, 鈴木 裕一朗, 岡本 哲平, 杉山 尚樹, 米山 高弘, 橋本 安弘, 古家 琢也, 米山 徹, 盛 和行, 神村 典孝, 大山 力

泌尿器外科   27 ( 4 )   519 - 519   2014.4

当科における男性不妊症に対する精巣内精子採取法の臨床成績

米山 高弘, 岡本 哲平, 得居 範子, 山本 勇人, 岡本 亜希子, 飛澤 悠葵, 米山 徹, 今井 篤, 盛 和行, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   102回   473 - 473   2014.4

腎平滑筋腫の1例

杉山 尚樹, 得居 範子, 岡本 哲平, 鈴木 裕一朗, 工藤 茂将, 米山 高弘, 橋本 安弘, 古家 琢也, 米山 徹, 盛 和行, 神村 典孝, 大山 力

泌尿器外科   27 ( 4 )   517 - 517   2014.4

腎門部に発生した毛細血管腫の1例

及川 真亮, 畠山 真吾, 田中 壽和, 田中 芳美, 成田 拓磨, 野呂 大輔, 萩原 和久, 米山 徹, 飛澤 悠葵, 鈴木 裕一朗, 杉山 尚樹, 盛 和行, 山本 勇人, 岡本 亜希子, 今井 篤, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   27 ( 4 )   548 - 548   2014.4

褐色細胞腫および傍神経節腫の外科的切除術における降圧効果の検討

山本 勇人, 今西 賢吾, 岡本 哲平, 得井 範子, 今井 篤, 飛澤 悠葵, 米山 徹, 畠山 真吾, 米山 高弘, 古家 琢也, 橋本 安弘, 二川原 健, 大山 力

日本泌尿器科学会総会   102回   588 - 588   2014.4

pT3およびPSA再発を術前に予測する新規前立腺癌悪性度診断マーカーの開発

飛澤 悠葵, 米山 徹, 畠山 真吾, 岡本 哲平, 岡本 亜希子, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

日本泌尿器科学会総会   102回   451 - 451   2014.4

Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience.

S Hatakeyama, T Fujita, R Murakami, Y Suzuki, N Sugiyama, H Yamamoto, A Okamoto, A Imai, Y Tobisawa, T Yoneyama, K Mori, T Yoneyama, Y Hashimoto, T Koie, S Narumi, C Ohyama

Transplantation proceedings   46 ( 2 )   445 - 448   2014.3

Post-transplant renal function and cardiovascular events are closely associated with the aortic calcification index in renal transplant recipients.

K Imanishi, S Hatakeyama, H Yamamoto, A Okamoto, A Imai, T Yoneyama, Y Hashimoto, T Koie, T Fujita, R Murakami, H Saitoh, T Funyu, S Narumi, C Ohyama

Transplantation proceedings   46 ( 2 )   484 - 488   2014.3

BK virus-associated urothelial carcinoma of a ureter graft in a renal transplant recipient: a case report.

M Oikawa, S Hatakeyama, T Fujita, R Murakami, K Hagiwara, T Narita, D Noro, T Tanaka, Y Tanaka, Y Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Y Hashimoto, T Koie, S Narumi, C Ohyama

Transplantation proceedings   46 ( 2 )   616 - 619   2014.3

Renal cell carcinoma detected by preoperative kidney transplant donor examination: a case report.

T Sato, Takahiro Yoneyama, K Hagiwara, T Narita, D Noro, T Tanaka, Y Tanaka, Y Tobisawa, Tohru Yoneyama, H Yamamoto, A Okamoto, A Imai, S Hatakeyama, Y Hashimoto, T Koie, C Ohyama

Transplantation proceedings   46 ( 2 )   634 - 636   2014.3

日本株BCG耐性膀胱癌細胞株の作出

盛 和行, 米山 徹, 飛澤 悠葵, 山本 勇人, 岡本 亜希子, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

泌尿器外科   27 ( 3 )   336 - 337   2014.3

Renal Cell Carcinoma Detected by Preoperative Kidney Transplant Donor Examination: A Case Report

T. Sato, Takahiro Yoneyama, K. Hagiwara, T. Narita, D. Noro, T. Tanaka, Y. Tanaka, Y. Tobisawa, Tohru Yoneyama, H. Yamamoto, A. Okamoto, A. Imai, S. Hatakeyama, Y. Hashimoto, T. Koie, C. Ohyama

TRANSPLANTATION PROCEEDINGS   46 ( 2 )   634 - 636   2014.3

BK Virus-Associated Urothelial Carcinoma of a Ureter Graft in a Renal Transplant Recipient: A Case Report

M. Oikawa, S. Hatakeyama, T. Fujita, R. Murakami, K. Hagiwara, T. Narita, D. Noro, T. Tanaka, Y. Tanaka, Y. Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Y. Hashimoto, T. Koie, S. Narumi, C. Ohyama

TRANSPLANTATION PROCEEDINGS   46 ( 2 )   616 - 619   2014.3

Outcome Comparison of ABO-Incompatible Kidney Transplantation With Low-Dose Rituximab and ABO-Compatible Kidney Transplantation: A Single-Center Experience

S. Hatakeyama, T. Fujita, R. Murakami, Y. Suzuki, N. Sugiyama, H. Yamamoto, A. Okamoto, A. Imai, Y. Tobisawa, T. Yoneyama, K. Mori, T. Yoneyama, Y. Hashimoto, T. Koie, S. Narumi, C. Ohyama

TRANSPLANTATION PROCEEDINGS   46 ( 2 )   445 - 448   2014.3

A Case of Malignant Pheochromocytoma Detected during Fertility Treatment.

Kazuhisa Hagiwara, Itsuto Hamano, Ayumu Kusaka, Hiromi Murasawa, Noriko Tokui, Kengo Imanishi, Akiko Okamoto, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Case reports in urology   2014   646743 - 646743   2014.2

A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.

Hiromichi Iwamura, Shingo Hatakeyama, Yoshimi Tanaka, Toshikazu Tanaka, Noriko Tokui, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuaki Yoshikawa, Chikara Ohyama

BMC research notes   7   64 - 64   2014.1

A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.

Hiromichi Iwamura, Shingo Hatakeyama, Yoshimi Tanaka, Toshikazu Tanaka, Noriko Tokui, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuaki Yoshikawa, Chikara Ohyama

BMC research notes   7   64 - 64   2014.1

Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient.

Takuya Narita, Itsuto Hamano, Ayumu Kusaka, Hiromi Murasawa, Noriko Tokui, Kengo Imanishi, Teppei Okamoto, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Kenichi Hakamada

Case reports in oncology   7 ( 1 )   233 - 238   2014.1

Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient.

Takuya Narita, Itsuto Hamano, Ayumu Kusaka, Hiromi Murasawa, Noriko Tokui, Kengo Imanishi, Teppei Okamoto, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Kenichi Hakamada

Case reports in oncology   7 ( 1 )   233 - 8   2014.1

Preoperative butyrylcholinesterase level as an independent predictor of overall survival in clear cell renal cell carcinoma patients treated with nephrectomy.

Takuya Koie, Chikara Ohyama, Jotaro Mikami, Hiromichi Iwamura, Naoki Fujita, Tendo Sato, Yuta Kojima, Ken Fukushi, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Masato Kitayama, Kazuyoshi Hirota

TheScientificWorldJournal   2014   1 - 5   2014

A Case of Malignant Pheochromocytoma Detected during Fertility Treatment.

Kazuhisa Hagiwara, Itsuto Hamano, Ayumu Kusaka, Hiromi Murasawa, Noriko Tokui, Kengo Imanishi, Akiko Okamoto, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Case reports in urology   2014   646743 - 646743   2014

Post-transplant renal function and cardiovascular events are closely associated with the aortic calcification index in renal transplant recipients

K. Imanishi, S. Hatakeyama, H. Yamamoto, A. Okamoto, A. Imai, T. Yoneyama, Y. Hashimoto, T. Koie, T. Fujita, R. Murakami, H. Saitoh, T. Funyu, S. Narumi, C. Ohyama

Transplantation Proceedings   46 ( 2 )   484 - 488   2014

Serum N-glycan profiling predicts prognosis in patients undergoing hemodialysis.

Shingo Hatakeyama, Maho Amano, Yuki Tobisawa, Tohru Yoneyama, Megumi Tsushima, Kazuko Hirose, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Shin-Ichiro Nishimura, Chikara Ohyama

TheScientificWorldJournal   2013   268407 - 268407   2013.12

Chromophobe renal cell carcinoma with concomitant sarcomatoid transformation and osseous metaplasia: a case report.

Yoshimi Tanaka, Takuya Koie, Shingo Hatakeyama, Yasuhiro Hashimoto, Chikara Ohyama

BMC urology   13   72 - 72   2013.12

Chromophobe renal cell carcinoma with concomitant sarcomatoid transformation and osseous metaplasia: a case report.

Yoshimi Tanaka, Takuya Koie, Shingo Hatakeyama, Yasuhiro Hashimoto, Chikara Ohyama

BMC urology   13   72 - 72   2013.12

Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.

Takuya Koie, Chikara Ohyama, Akiko Okamoto, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto

BMC research notes   6   484 - 484   2013.11

Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.

Takuya Koie, Chikara Ohyama, Akiko Okamoto, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto

BMC research notes   6   484 - 484   2013.11

Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center.

Shingo Hatakeyama, Takahiro Yoneyama, Itsuto Hamano, Hiromi Murasawa, Takuma Narita, Masaaki Oikawa, Kazuhisa Hagiwara, Daisuke Noro, Toshikazu Tanaka, Yoshimi Tanaka, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

BMC urology   13   47 - 47   2013.10

Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center.

Shingo Hatakeyama, Takahiro Yoneyama, Itsuto Hamano, Hiromi Murasawa, Takuma Narita, Masaaki Oikawa, Kazuhisa Hagiwara, Daisuke Noro, Toshikazu Tanaka, Yoshimi Tanaka, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

BMC urology   13   47 - 47   2013.10

Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis.

Shingo Hatakeyama, Hiromi Murasawa, Takuma Narita, Masaaki Oikawa, Naoki Fujita, Hiromichi Iwamura, Joutaro Mikami, Yuta Kojima, Tendo Sato, Ken Fukushi, Yusuke Ishibashi, Yasuhiro Hashimoto, Takuya Koie, Hisao Saitoh, Tomihisa Funyu, Chikara Ohyama

BMC nephrology   14   222 - 222   2013.10

Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis.

Shingo Hatakeyama, Hiromi Murasawa, Takuma Narita, Masaaki Oikawa, Naoki Fujita, Hiromichi Iwamura, Joutaro Mikami, Yuta Kojima, Tendo Sato, Ken Fukushi, Yusuke Ishibashi, Yasuhiro Hashimoto, Takuya Koie, Hisao Saitoh, Tomihisa Funyu, Chikara Ohyama

BMC nephrology   14   222 - 222   2013.10

Prognosis of elderly Japanese patients aged ≥80 years undergoing hemodialysis.

Shingo Hatakeyama, Hiromi Murasawa, Itsuto Hamano, Ayumu Kusaka, Takuma Narita, Masaaki Oikawa, Daisuke Noro, Kazuhisa Hagiwara, Hirofumi Ishimura, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hisao Saitoh, Tomihisa Funyu, Chikara Ohyama

TheScientificWorldJournal   2013   693514 - 693514   2013.10

BCG抵抗性膀胱癌細胞株作出の試み BCG failureの原因を探るために

盛 和行, 飛澤 悠葵, 米山 徹, 鈴木 裕一朗, 杉山 尚樹, 山本 勇人, 岡本 亜希子, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 古家 琢也, 大山 力

日本癌治療学会誌   48 ( 3 )   1631 - 1631   2013.9

Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.

Koie T, Ohyama C, Hashimoto Y, Hatakeyama S, Yamamoto H, Yoneyama T, Kamimura N

Int J Clin Oncol.   2013.8

Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.

Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Shingo Hatakeyama, Hayato Yamamoto, Takahiro Yoneyama, Noritaka Kamimura

International journal of clinical oncology   18 ( 4 )   724 - 30   2013.8

Ureteral Endometriosis Treated by Hormonal Therapy : A Case Report

Mikami Jotaro, Yamamoto Hayato, Okamoto Akiko, Ishimura Hirofumi, Imai Atsushi, Hatakeyama Shingo, Yoneyama Takahiro, Hashimoto Yasuhiro, Koie Takuya, Ohyama Chikara

Hinyokika Kiyo   59 ( 7 )   431 - 434   2013.7

[Successful control of hyper-cortisolemia due to ACTH-producing thyroid carcinoid by laparoscopic bilateral adrenalectomy : a case report].

Yuta Kojima, Noritaka Kamimura, Hayato Yamamoto, Hiromi Murasawa, Akiko Okamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica   59 ( 7 )   419 - 22   2013.7

Successful Control of Hyper-Cortisolemia Due to ACTH-Producing Thyroid Carcinoid by Laparoscopic Bilateral Adrenalectomy : A Case Report

Kojima Yuta, Kamimura Noritaka, Yamamoto Hayato, Murasawa Hiromi, Okamoto Akiko, Imai Atsushi, Hatakeyama Shingo, Yoneyama Takahiro, Hashimoto Yasuhiro, Koie Takuya, Ohyama Chikara

Hinyokika Kiyo   59 ( 7 )   419 - 422   2013.7

[Ureteral endometriosis treated by hormonal therapy : a case report].

Jotaro Mikami, Hayato Yamamoto, Akiko Okamoto, Hirofumi Ishimura, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica   59 ( 7 )   431 - 4   2013.7